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Magnetic Resonance Imaging (MRI) has now entered in clinical 
practice as a radiation-free diagnostic imaging thanks to the 
increasingly availability of MR scanner and the ongoing technical 
improvement. Moreover, the development of innovative sequence 
techniques, such as Perfusion imaging (PwI), Diffusion imaging 
(DwI) and mapping techniques, allowed to progress from 
morphological MRI to functional MRI and from qualitative 
evaluation to quantitative analysis. Therefore, advanced MRI is able 
to provide new and useful diagnostic data in cardiothoracic and 
abdominal imaging. The most recent advanced MRI technique is the 
Radiomics, which deserves its own chapter. 
 
Advanced MRI in Thoracic Imaging 
In the study of the lung, current MRI techniques enable functional 
imaging allowing for a comprehensive assessment of lung disease. 
PwI can quantitatively evaluate the combined effects of plasma blood 
flow, permeability, and capillary surface area. Therefore, PwI of the 
lung is revealing as an alternative to nuclear medicine in the 
assessment of pulmonary perfusion. This technique is suitable for the 
quantitative analysis of regional pulmonary blood flow in order to 
obtain an objectively assessment. Pulmonary blood flow (PBF), mean 
transit time (MTT), and pulmonary blood volume (PBV) can be 
calculated (Henzler et al. Eur J Radiol 2010). 
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Indications for the assessment of pulmonary perfusion are various. 
Perfusion MRI showed a higher diagnostic accuracy for the detection 
of pulmonary embolism when compared to multi-detector CT and 
ventilation-perfusion scintigraphy (Ohno et al. AJR Am J Roentgenol 
2004). Perfusion MRI has an application also in patients with cystic 
fibrosis in order to study changes in regional lung perfusion due to 
the hypoxic vasoconstriction; perfusion MRI showed a good 
agreement to pulmonary function tests and radionuclide lung 
scintigraphy (Eichinger et al. Eur Radiol 2006). In patients with 
chronic obstructive pulmonary disease, quantitative perfusion MRI 
shows a reduction of mean PBF, MTT, and PBV and it is more 
accurate than radionuclide scintigraphy in detecting perfusion 
abnormalities in these patients (Fink et al. Radiology 2004). Finally, 
MR perfusion may be used to improve therapy planning and to 
predict the postoperative lung function (Henzler et al. Eur J Radiol 
2010). 
In the last years, DwI of the thorax has become feasible thanks to the 
developments of innovative techniques allowing a significant 
reduction of the artifacts from respiratory and cardiac motion. DwI is 
able to provide an assessment of tumor cellular cramming. In chest 
imaging, the mainly application of DwI is for the characterization of 
lung cancer, lymph nodes and pulmonary metastases (Henzler et al. 
Eur J Radiol 2010). As other malignant tumors, lung cancer is 
characterized by increased cellularity so that the diffusion of water 
molecules is restricted, resulting in decreased apparent diffusion 
coefficient (ADC) (Padhani et al. Neoplasia 2009). Ohba et al. 
showed that DwI is equivalent to PET in differentiating malignant 
and benign lung nodules (Ohba et al. J Thorac Cardiovasc Surg 
2009). DwI may be also used to the M- and N-staging of lung cancer. 
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The whole- body MRI with DwI showed a good accuracy for M-
stage assessment in patients with non-small cell lung cancer (Ohno et 
al. Radiology 2008). In differentiating metastatic and non-metastatic 
lymph node stations DwI is more accurate than PET-CT because of 
fewer false-positive results (Naruke et al. J Thorac Cardiovasc Surg 
1978). 
DwI and PwI are promising tools for evaluation of early response to 
chemotherapy or radiotherapy, in particular for the assessment of 
mediastinal residual masses in patients with Hodgkin's and non-
Hodgkin's lymphoma (Henzler et al. Eur J Radiol 2010). Our 
research group carried out a prospective study to compare the 
diagnostic performance of advanced MRI (DwI and PwI) with 
PET/CT in the assessment of residual masses in patients with 
lymphoma. In particular, we aimed to investigate whether MRI can 
decrease the false-positive or false-negative rate and can be a valid 
alternative to PET/CT evaluations. We enrolled 25 consecutive 
patients (17 females and 8 males aged 40.5 ±16 years) with a 
histological diagnosis of lymphoma, and who had residual disease of 
≥ 3 cm at the end of therapy. All patients underwent MRI and 
PET/CT 3–4 months after the end of immuno-chemotherapy and 
chemotherapy plus radiotherapy. The residual masses were analyzed 
by 2 radiologists experienced in MRI. They evaluated 3 parameters: 
morphological-contrastographic (MC) features, DwI, and PwI. The 
residual disease was defined as being active if 2 or 3 of the 
parameters were positive and inactive if 2 or 3 parameters were 
negative. PET/CT used a 5-point scale (based on the Deauville 
criteria) for the end-of-therapy response assessment of residual 
disease. Scores of 1–3 were considered negative for residual disease. 
The diagnostic accuracy of MRI and PET/CT was calculated by 
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considering the 6-month follow-up as the standard of reference. 
According to the histology data of the 25 patients, 8 (32%) had HL, 5 
(20%) had gray-zone lymphoma (GZL), and 12 (48%) had NHL (8 
with primary mediastinal large B cell lymphoma, 2 with diffuse large 
B cell lymphoma, and 2 with follicular lymphoma). At the 6-month 
follow-up, 22 patients showed a complete remission and 3 had a 
partial remission. No statistically significant differences were found 
between the false-positive or false-negative errors on MRI and 
PET/CT ( p = 0.46 and p = 1, respectively). The agreement between 
the 2 radiologists for the MRI evaluation was excellent (κ = 1). 
The specificity, negative predictive value, and accuracy were 86, 95, 
and 84% and 73, 89, and 68% for MRI and PET/CT, respectively. 
MRI and PET/CT results correlated in 19 of 25 cases (agreement rate 
= fair; κ = 0.35). Upon review of the 6 discrepant cases, 4 were false-
positive PET/CT errors, 1 was a false-positive MRI error, and 1 was 
a false-negative PET/CT error. In conclusion, our results showed that 
advanced MRI had greater diagnostic accuracy than PET/CT for the 
evaluation of the residual masses in lymphoma at the 6-month 
follow-up (84 vs. 68%). At the end of therapy, it could be used to 
confirm a positive or negative PET/CT result. During long-term 
follow-up, it could be an alternative technique when the first check-
up of the residual mass on PET/CT is negative (Calistri et al. Acta 
Haematol 2018). 
Advanced MRI in Cardiac Imaging  
Cardiac MRI is currently considered the gold standard for myocardial 
characterization (Cummings et al. RadioGraphics 2009). In spite of 
this potential capability, the traditional Cardiac MR sequences 
provide only a subjective qualitative analysis of signal intensity. 
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Newer T1 and T2 myocardial mapping techniques offer a quantitative 
assessment of the myocardium (by using T1 and T2 relaxation times), 
which can be helpful in focal disease and especially in the evaluation 
of diffuse myocardial disease (e.g. edema and fibrosis) (Hamlin et al. 
Radiographics 2014). 
Myocardial edema can be evaluated using T2 mapping techniques. 
These have shown a superior performance compared to the traditional 
T2-weighted and STIR sequences (Ferreira et al. J Thorac Imaging 
2014). T2 mapping can detect edematous myocardial territories in a 
variety of cardiac pathologies, including acute myocardial infarction, 
myocarditis, Tako-tsubo cardiomyopathy, and heart transplant 
rejection.  
T1 mapping techniques, performed both with and without contrast 
medium, enable to quantify diffuse myocardial fibrosis and to assess 
myocardial edema and infiltration. Native myocardial T1 values have 
been reported to be elevated in a lot of cardiac diseases including 
myocardial infarction, myocarditis, hypertrophic and dilated 
cardiomyopathy and cardiac amyloidosis. Reduced T1 times in the 
myocardium have been reported in presence of fat inside cardiac 
masses, in Anderson-Fabry disease, and in myocardial siderosis 
(Ferreira et al. J Thorac Imaging 2014).  
In addition, non-enhanced and contrast-enhanced T1 mapping are 
useful, in conjunction with the hematocrit value, for calculating the 
extracellular volume fraction (ECV), a measure of the proportion of 
extracellular space within the myocardium. ECV quantification is 
more reproducible across different vendors and different acquisition 
techniques than T1 values. ECV can be used to identify and 
characterize diffuse fibrosis or subtle myocardial abnormalities 
(Hamlin et al. Radiographics 2014).  
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In our retrospective study to evaluate the incidence of late-
gadolinium-enhancement (LGE) in mitral valve prolapse (MVP), and 
its association with the degree of mitral regurgitation (MR) and/or 
with complex ventricular arrhythmia (ComVA), we also analysed the 
role of T1 mapping in the evaluation of MVP patients. We found that 
patients with MVP had higher native T1-values, lower post-contrast 
T1-values and increased ECV-values compared with controls 
(p=0.01, 0.01 and 0.00, respectively). T1 mapping significantly 
confirmed LGE and it was more sensitive in identifying alterations in 
one patient. However, no significant associations between the MR 
severity and ComVA and T1/ECV values were found (Pradella et al. 
European Radiology 2018). 
Perfusion CMR imaging has been shown to be an important method 
to diagnose myocardial ischemia, to predict the hemodynamic 
significance of coronary stenosis and to determine the prognosis after 
myocardial reperfusion. Stress myocardial perfusion MRI has a 
diagnostic accuracy similar to PET in ruling out hemodynamically 
significant coronary artery disease (Takx et al. Circ Cardiovasc 
Imaging. 2015). 
 
Advanced MRI in Abdominal Imaging 
DwI and PwI techniques are increasingly used in the abdomen 
particularly in the evaluation of diffuse and focal liver diseases. 
Thanks to its high tissue contrast, DwI allows the detection of hepatic 
focal lesions with a great sensitivity and it has been considered an 
alternative to gadolinium-enhanced T1 weighted imaging for 
detection of liver metastases. Furthermore, several studies showed 
that DwI in association with gadolinium-enhanced MRI increases 
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sensitivity for detection of hepatocellular carcinomas (Li et al. PLoS 
One. 2015). DwI may be helpful in lesion characterization, 
differentiating between benign from malignant lesions on the base of 
ADC values. In our retrospective study on 25 patients with 
pathologically proven primary hepatic lymphoma (PHL) we found 
that all the PHLs showed restricted diffusion on DwI with ADC 
values lower than of the other hepatic lesions (Colagrande et al. 
Abdom Radiol 2018).  
ADC measurements have also a potential predictive value of 
treatment response, because mean ADC increases in metastases or 
tumor with at least a partial response to chemotherapy (Koh et al. Am 
J  Roentgenol 2007). DwI plays a role also in diffuse liver disease. 
Lewin et al. found an excellent correlation between ADC values and 
FibroScan® (sonographic elastography technique) and serum 
markers of fibrosis; ADC values are lower in patients with moderate-
to-severe fibrosis than those with mild fibrosis and healthy volunteers 
(Lewin et al. Hepatology  2007). 
Liver perfusion MRI is currently being actively investigated as a 
functional imaging technique that allows the characterization of the 
angiogenic activity of HCC and liver metastases, especially helpful 
for predicting and monitoring treatment response to antiangiogenic 
therapy (Chandarana et al. Eur J Radiol. 2010). 
 
Radiomics 
Radiomics is a novel image analysis technique, whereby digital 
images are converted to data that can be analysed to derive multiple 
numerical quantifiers of shape and tissue character—referred to as 
‘radiomics features’. With radiomics, it is now possible to rapidly 
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extract innumerable quantitative features from tomographic images 
(computed tomography [CT], magnetic resonance [MR], or positron 
emission tomography [PET] images). Radiomics is motivated by the 
concept that biomedical images contain information that reflects 
underlying pathophysiology and that these relationships can be 
revealed via quantitative image analyses. Thus, radiomics features 
may be used as predictor variables in statistical models for diagnosis 
or outcome prediction. Radiomics has been initiated in oncology 
studies, but it is potentially applicable to all diseases. Quantitative 
image features based on intensity, shape, size or volume, and texture 
offer information on tumor phenotype and microenvironment (or 
habitat) that is distinct from that provided by clinical reports, 
laboratory test results, and genomic or proteomic assays. Radiomics 
models have had notable success in oncology, where their utility in 
classification of tumours, prediction of treatment response, and 
prognostication has been demonstrated in multiple cohorts (Gillies et 
al. Radiology 2016). 
For a clinical radiologist, radiomics has the potential to help with the 
diagnosis of both common and rare tumors. Visualization of tumor 
heterogeneity may prove critical in the assessment of tumor 
aggressiveness and prognosis. For example, research has already 
shown the capacity of radiomics analyses to help distinguish prostate 
cancer from benign prostate tissue or add information about prostate 
cancer aggressiveness (Wibmer et al. Eur Radiol 2015). In the 
evaluation of lung cancer and in the evaluation of glioblastoma 
multiforme, radiomics has been shown to be a tool with which to 
assess patient prognosis (Coroller et al. Radiother Oncol 2015). Many 
studies revealed that radiomics can help predict tumor grade. 
(Shiradkar et al. J Magn Reson Imaging 2018; Lambin et al. Eur J 
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Cancer 2012; Kumar et al. Magn Reson Imaging 2012). Good results 
have been achieved in terms of grading classification by radiomics in 
clear cell renal cell carcinoma, colorectal adenocarcinoma, and 
gliomas (Ding et al. European journal of radiology 2018; Huang et al. 
Academic radiology vol. 25,10 2018; Tian et al. Journal of magnetic 
resonance imaging 2018). 
However, radiomics can be applied to a large number of conditions 
and there is a growing interest in using it in cardiac imaging where 
experience with radiomics is still limited. Texture analysis is the most 
common type of radiomic analysis performed in CMR imaging 
(Hassani et al. AJR Am J Roentgenol. 2020). Some studies showed 
that texture analysis of unenhanced CMR images could be 
successfully used to identify, differentiate, and diagnose 
cardiomyopathies (Schofield et al. Clin Radiol 2019; Shao et al. 
Medicine Baltimore 2018). On this background, we chose to focus 
our study on radiomics in cardiac imaging because the experience in 
this field is still limited. 
The practice of radiomics involves discrete steps each with its own 
challenges. These steps include: (a) image acquisition, (b) volumes of 
interest identification, (c) segmentation (ie, delineating the borders of 
the volume), (d) feature extraction from the volume, (e) feature 
selection, and (f) mining these data to develop classifier models to 
predict outcomes either alone or in combination with additional 
information, such as demographic, clinical, comorbidity, or genomic 
data. 
Image acquisition. Radiomics analysis can be applied to standard, 
routinely acquired clinical images. However, Modern CT, MR 
imaging, and combined PET/CT units allow for wide variations in 
acquisition and image reconstruction protocols, and standardization 
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of these protocols across medical imaging centers is typically 
lacking. These are technical challenges to the individual steps in the 
process of radiomics because variations in acquisition and image 
reconstruction parameters can introduce changes that are not due to 
underlying biologic effects. CT-based studies of reproducibility have 
shown that differences in acquisition and reconstruction settings can 
significantly alter radiomic results (Midya et al. J Med Imaging 
Bellingham 2018; Kim et al. PLoS One 2016). Others studies do 
report significant differences in radiomic reproducibility depending 
on differences in MR image acquisition, which type of MRI 
sequence, and which radiomic feature is being analyzed (Traverso et 
al. Int J Radiat Oncol Biol Phys 2018; Shiri et al. Iran J Radiol 2017). 
Thus, reproducibility of any given radiomic study is a constant 
challenge. The most rigorous radiomics investigation requires a 
prospective multicenter trial wherein acquisition and image 
reconstruction protocols are standardized.  
Volume of Interest Identification and Segmentation. Once the image 
to be used is selected, the area for radiomics analysis is defined by 
contouring a region of interest (ROI). The ROI may be a limited area 
or multiple areas.  As the radiomics features are extracted from the 
defined areas, variations in contouring that alter the ROI will change 
the values of the radiomics features. Thus, segmentation is the most 
critical, challenging, and contentious component of radiomics. There 
are ongoing debates over whether to seek ground truth or 
reproducibility and how much to rely on manual or automatic 
segmentation. However, a consensus is emerging that truth is elusive 
and that optimum reproducible segmentation is achievable with 
computer-aided edge detection followed by manual curation. It is 
well recognized that interoperator variability of manually contoured 
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tumors is high (Rios Velazquez et al. Radiother Oncol 2012). 
Segmentation of normal structures, such as skeletal elements and 
organs, can now be achieved with full automation. However, any 
disease, especially cancer, requires operator input because of inter- 
and intrasubject morphologic and contrast heterogeneity at the initial 
examination (Gillies et al. Radiology 2016). 
Feature Extraction. The heart of radiomics is the extraction of high-
dimension feature data to quantitatively describe attributes of 
volumes of interest. Extraction of radiomics features from the 
segmented ROI can be performed through dedicated pipelines 
developed by individual centres or using open-source packages, such 
as 3D-slicer.  Radiomics features include Shape features and agnostic 
features that can be divided into first-, second-, or higher order 
statistical outputs (subsumed under the term “texture analysis” [TA]). 
Radiomics shape features quantify the 3D size and shape of the 
segmented volume. Radiomics shape features include conventional 
indices (e.g. volume), as well as additional parameters, such as 
surface area and dimensions in multiple planes. There are also 
descriptors of the overall shape of the ROI, such as compactness, 
sphericity, elongation, and flatness. Texture features are derived by 
assigning a signal intensity (SI) level to each voxel in the region of 
interest and considering the pattern and relationships between 
different voxel signal intensities through application of various 
mathematical processes. This is a slightly more abstract concept in 
comparison to the shape analysis. The first step to performing 
radiomics texture analysis is construction of a ‘SI matrix’, whereby 
each voxel within the ROI is assigned a number (level/value) 
depending on the intensity of signal in that voxel. The SI value for 
every voxel in the ROI is then tabulated to form a simple matrix. All 
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SI-based radiomics features are derived from analysis of the SI 
matrix. The most straightforward analysis of the SI matrix involves 
creating a histogram of the SI levels identified in the ROI and the 
frequency with which they are observed. From this, first-order 
histogram-based statistics can be computed. This includes simple 
descriptive summary statistics, such as mean, median, and standard 
deviation, as well as less familiar measures of skewness (asymmetry), 
kurtosis (flatness), and entropy (randomness or disorder). These 
histogram-based texture features describe the distribution of values of 
individual voxels without concern for spatial relationships. In order 
to consider the relationship of neighbouring voxel SIs, more complex 
mathematical approaches to analysis of the SI matrix are required. 
These features are derived by considering the spatial distribution of 
SIs within the ROI and aim to quantify heterogeneity, repeatability, 
and complexity of the SI matrix. For instance, a common approach 
for considering the relationship between voxel pairs is through 
construction of a grey-level co-occurrence matrix (GLCM). The 
GLCM is constructed by tabulating the frequency of different SI 
pairings occurring within the SI matrix. Different mathematical 
processes are then applied to the GLCM to compute, according to 
agreed definitions, measures, such as angular second moment 
(homogeneity), contrast (local variation), and entropy (disorder or 
randomness). These features reflect the probability of certain SI 
pairings, the level of greylevel variation interdependencies, and the 
extent of disorder within the ROI. The grey-level run length matrix 
(GLRLM) is another commonly constructed matrix. It can be used to 
consider the spatial relationship of any number of voxels (not just 
pairs). A GLRLM is constructed by recording the number of times a 
voxel with a specific SI is seen in an uninterrupted run within the 
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image SI matrix in a specified direction. The GLRLM is used to 
calculate a number of features such as short-run emphasis, run-length 
non-uniformity, and run entropy. A number of other matrices, 
tabulated according to different rules, are also available for 
calculation of additional features [grey-level size zone matrix 
(GLSZM), grey-level difference matrix (GLDM), and neighbouring 
grey tone difference matrix (NGTDM)] (Raisi-Estabragh et al. 
European Heart Journal - Cardiovascular Imaging 2020). Thus, 
Second-order statistical descriptors describe statistical 
interrelationships between voxels with similar (or dissimilar) contrast 
values. Finally, Higher-order statistical methods impose filter grids 
on the image to extract repetitive or nonrepetitive patterns. These 
include fractal analyses, wherein patterns are imposed on the image 
and the number of grid elements containing voxels of a specified 
value is computed; Minkowski functionals, which assess patterns of 
voxels whose intensity is above a threshold; wavelets, which are filter 
transforms that multiply an image by a matrix of complex linear or 
radial “waves”; and Laplacian transforms of Gaussian bandpass 
filters that can extract areas with increasingly coarse texture patterns 
from the image (Gillies et al. Radiology 2016). 
Feature selection. The process of feature extraction will yield a large 
number of radiomics features (100–1000 s). The aim is to use the 
extracted features as predictor variables within a statistical model for 
disease classification or outcome prediction. The number of extracted 
radiomics features often far exceeds the sample size of cohorts used 
for model building. Using all the extracted features in a statistical 
model would lead to overfitting. Therefore, we need to select a 
reduced number of features for model building.  The purpose of 
feature selection is to identify the optimal set of radiomics features to 
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be taken forward for model building. We would aim to include in the 
model features that are most informative and robust and remove 
those that are unstable or provide repetitive information. Various 
methods may be used to identify such highly correlated features and 
select the most informative. 
The most popular approaches are unsupervised machine learning 
methods such as clustering and principal component analysis. 
Clustering algorithms group features into clusters based on high 
correlation with each other (inter-cluster correlation) and low 
correlation with other features (extra-cluster correlation). The 
algorithm then identifies the most defining feature from each cluster 
for inclusion in the model and removes the rest. Principal component 
analysis through different methods reduces the extracted features to a 
subset that provides nearly as much information as the whole feature-
set. Regardless of the method used for feature selection, the common 
goal is identification of a reduced set of radiomics features that are 
robust, informative, and non-redundant for inclusion in the predictive 
model (Raisi-Estabragh et al. European Heart Journal - 
Cardiovascular Imaging 2020). 
Model building. Once we have identified the final set of radiomics 
features through feature selection, we can begin to build our 
classification model. The predictor/discriminatory variables will be 
the radiomics features (input) and the output will be the desired label. 
To build the model, we require a sample (training set) of example 
cases (training examples) with known inputs and outputs, from which 
we have extracted and selected our features. In some cases, logistic 
regression will be adequate to address a simple classification 
problem. More commonly, machine learning algorithms are used to 
train different models, from these, the model with the best 
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performance is selected. Support vector machines (SVMs) are a 
commonly used machine learning algorithm for addressing 
classification problems with capability of modelling both linear and 
non-linear (SVMwith kernels) relationships. The SVM identifies all 
the hyperplanes that could separate the different classes within the 
training set and selects the one that maximizes the margins between 
classes (Raisi-Estabragh et al. European Heart Journal - 
Cardiovascular Imaging 2020). 
 
Cardiac Magnetic Resonance 
In 1977, the first magnetic resonance scan of a human body was 
accomplished, but the required scan time of almost 5 hours prevented 
use of this technology as a clinical tool (Damadian et. al FONAR 
image of the live human body 1977). Further refinement of the 
technique in the 1980’s resulted in electrocardiography (ECG)-gated 
Cardiovascular Magnetic Resonance imaging (CMR) of the heart 
(Didier et al Thieme 2003). As a result of various developments in 
terms of hardware, pulse sequences, and the ability of post-
processsing techniques, CMR nowadays allows us to depict 
cardiovascular anatomy with a high spatial and temporal resolution. 
These image sequences permit not only the morphological 
examination of the heart, including left ventricular dimensions, but 
they also make functional assessment possible, including accurate 
and reproducible assessment of left ventricular (LV) function. This 
has enabled CMR to emerge as a powerful tool for physicians to 
diagnose various cardiac pathologies, guide therapies, and predict 
outcome and prognosis (Bruder et al. J Cardiovasc Magn Reson 
2013). 
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Furthermore, CMR is able to characterize myocardial tissue after the 
administration of gadolinum, so-called Late Gadolinium-Enhanced 
CMR (LGE-CMR) (Shulz-Menger et al. J Cardiovasc Magn Reson 
2013), which previously has been referred to as Contrast-Enhanced 
CMR (CE-CMR) or Delayed-Enhanced CMR (DE-CMR). This 
technical approach can be valuable for the evaluation of both patients 
with ischemic heart disease, who developed a myocardial infarction, 
as well as for patients with non-ischemic heart diseases, as for 
instance myocarditis. Currently, CMR is considered the “gold” 
standard for non-invasive assessment of LV function and tissue 
characterization (Pilz et al. Minerva Cardioangiol 2009). CMR is 
undergoing a rapid, continuous evolution and other new CMR 
techniques, such as T1 and T2 mapping, are available. 
 
Basic Physics of CMR 
	
The basic principles of MRI are the same irrespective of the part of 
the body. However, there are specific areas of MRI physics that are 
particularly important for CMR (i.e. motion compensation and 
cardiac relevant MRI sequences).  
MRI is based on nuclear magnetic resonance, the phenomenon of the 
resonance of atomic nuclei in response to radiofrequency (RF) 
waves. The presence of an external magnetic field (B0) is used to 
align the nuclear magnetization of hydrogen atoms (H+, protons), 
which are abundant in the human body. In quantum terms, nuclei 
align either parallel or antiparallel to the B0 field due to the fact that 
protons can occupy multiple energy states. Low-energy protons line 
up parallel to B0 while high-energy protons line up antiparallel. There 
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is always a small excess of parallel protons and thus the net magnetic 
vector (NMV) is in the direction of the B0 field.  
In the presence of a B0 field the protons do not simply line up, they 
actually precess around the B0 axis (Fig. 1a). The precessional 
frequency (ω) of a MR active nucleus is given by the Larmor 
equation: ω = γ B0, where γ is the gyromagentic constant, a nuclei 
specific constant. Hydrogen exposed to a 1.5T field precess around 
the B0 axis at approximately 64 MHz. When protons precess in 
synchrony they are said to be in-phase. When they are out of phase 
with each other, the NMV does not precess and only has a component 
in the direction of the B0 field.  
These hydrogen nuclei are then excited intermittently by pulses of 
radiofrequency (RF) waves (a magnetic resonance [MR] sequence), 
and the signal emitted from the body in return is detected with MR 
receiver coils. Specifically, the RF energy, inputted into the system, 
causes moving of NMV (M0) toward a plane perpendicular to the B0 











Fig 1. A) Proton spinning around its own axis while precessing around the z-axis 
(i.e. the direction of the static field). B) RF excitation causing flipping of z 
magnetization into the x–y plane  
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Therefore, if the B
0 field is assumed to be in the z direction (along the 
bore of the MR scanner), RF excitation cause the flipping of M0 from 
z to the the x–y plane (Fig. 1b). The flip angle is dependent on the 
strength and duration of RF pulse, with a 90o flip placing all the 
longitudinal magnetization into the transverse plane. The flipped 
magnetization vector now has a transverse component, which forms 
the basis of the MR signal.  
Faraday’s law of electromagnetic induction states voltage will be 
induced in a conductor exposed to a changing magnetic field. 
Longitudinal magnetization does not change and therefore it cannot 
induce a voltage. Transverse magnetization on the other hand rotates 
in the x–y plane and therefore it will induce a voltage in a conductor. 
This is an important point to note: only the transverse component of 
M
0 induces voltage. However this signal does not stay the same 
indefinitely, but rather relaxes back to its resting state. It is this 
relaxation that forms the basis of MRI contrast. Relaxation is the 
process by which magnetization returns to its resting state after RF 
excitation. There are two processes involved (T1 and T2 relaxation), 
both of which are dependent on the atomic arrangement within 
tissues. Thus, the rate of relaxation is tissue specific and can be used 
to develop tissue contrast.  
T1 relaxation times measure the time after excitation to recover the 
longitudinal magnetisation found in the equilibrium state. Transverse 
magnetisation decays at a rate measured by T2, which is faster than 
the rate of T1 recovery. T1 and T2 relaxation vary according to the 
environment of the H+ atom within tissues and imaging sequences can 
be designed with different preference (or weighting) to one of these 
relaxation parameters for tissue characterisation, known as T1-
weighted (T1W) and T2-weighted (T2W) acquisitions. T1 relaxation 
(longitudinal relaxation) is due to transfer of energy from high-
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energy protons to the surrounding lattice (spin-lattice relaxation). 
This causes the NMV to flip back into the z direction; during this 
process longitudinal magnetization recovers exponentially. As T1 
depends on the atomic structure of the tissue, it is a tissue-specific 
constant. In tissues with a short T1 (such as fat) longitudinal 
magnetization will be recovered more quickly (hyperintensity signal) 
than in tissue with a longer T1 (such as muscle) (hypointesity signal). 
The nature of the exponential recovery curve means that when time 


















Fig 2. T1 relaxation curve. 
 
The other relaxation process is T2 relaxation (transverse relaxation) 
and is due to dephasing of the individual spins leading to a reduction 
in coherent transverse magnetization. This is due to the interaction 
between the magnetic fields of adjacent protons (spin–spin 
interactions) and results in different protons precessing at different 
rates. In the rotating frame of reference, this variation in frequency is 
seen as dephasing. Thus, the coherent magnetization vector in the x–
y plane starts to fan out resulting in a reduction in the net transverse 
magnetization. Transverse relaxation results in exponential decay of 
coherent transverse magnetization at a rate governed by T2 (Fig.3). 
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Thus, when time equals T2, transverse magnetization will have 
decayed to 37% of its original value. Much like T1, T2 also depends 
on the atomic structure of the tissue, and is therefore an independent 
tissue-specific constant. In tissues with a long T2 (such as tissue with 
a high water content) transverse magnetization will persist longer 
(hyperintense signal) than tissue in tissue with a shorter T2 (such as 
fat) (hypointense signal). However, there is a second process that 
results in loss of transverse magnetization. This is B0 field 
inhomogeneity, which also results in dephasing. This accelerated 
dephasing is encapsulated in the time constant T2*. The T2* value is 
dependant on the underlying T2 and any field inhomogeneity and is 




















Spatial Encoding and Image Construction  
	
The basic purpose of imaging is to understand how an object 
occupies space. In all cases this requires interaction with the object 
and subsequent collection of spatially encoded measurements. In 
MRI, the induced signal is spatially encoded by magnetic gradient 
fields (a magnetic field whose strength varies with space). As we 
know the precessional frequency is directly proportional to the 
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magnetic field. Thus, a magnetic gradient results in a spatially 
varying precessional frequency. In the rotating frame of reference, a 
magnetic gradient results in a spatial variation in the phase of the MR 
signal from different areas. The total MR signal is the vectoral sum of 
the signals from each area and will now be dependant on the spatial 
distribution of protons. Because there is more than one distribution of 
protons that will give the same total MR signal we need to perform 
more ‘experiments’ with different gradients. In this way we reach a 
point where there was only one possible distribution that fits all the 
collected MR signals. In fact, to create an image with x number of 
pixels we have to perform x number of experiments or independent 
measurements. Each independent measurement requires an MR 
signal to be acquired under a different magnetic gradient (producing 
different amounts of spatially dependant dephasing).  
 
Motion Compensation  
	
More than any other type of MRI, CMR has to compensate for 
motion in order to achieve acceptable image quality. Therefore, MRI 
sequences must be adjusted to account for cardio-respiratory motion. 
To prevent artifacts from cardiac motion, most CMR images are 
generated with fast sequences gated to the R-wave of the 
electrocardiogram. Respiratory motion, another source of artifacts, is 
usually eliminated by acquiring CMR images in end-expiratory 
breath-hold. 
The purpose of ECG gating is to ‘freeze’ cardiac motion and this is 
possible with “segmented k-space acquisition”. 
MRI signals are stored in a structure called k-space. A position in k-
space is proportional to the gradient moment, with the center of k-
space coinciding with a zero moment (i.e. no gradient applied) and 
the edge with the highest moment. Therefore, K-space is a spatial 
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frequency domain. Thus, a point in k-space represents a given spatial 
frequency, and not a point in the image. The central portions of k-
space encode the low spatial frequencies that equate to the broad 
contrast in the image, essentially blobs of signal rather than defined 
objects. The outer portions of k-space encode the higher spatial 
frequencies that define the edge of an image—the higher the 
frequency the sharper the edge.  
One-way to freeze motion when performing traditional k-space 
filling is to divide k-space into segments and fill each segment in 
successive R–R intervals. This is called a segmented k-space 
acquisition (Finn and Edelman 1993). If the time taken to fill a 
segment is short or the myocardium is relatively still, motion is 
essentially frozen. Reducing the number of lines per segment should 
improve image sharpness. However, reducing the number of lines per 
segment increases the number of k-space segments. As each segment 
is acquired in a single R–R interval, increasing the number of 
segments increases total acquisition time. The segmented k-space 
approach is the basis of cardiac gating for both single-phase and 
multi-phase acquisitions.  
Single-Phase Acquisitions are used in many types of CMR, such as 
morphological imaging (e.g. coronary CMR angiography) or tissue 
characterization (e.g. late gadolinium enhancement) in order to obtain 
a static image of the heart. CMR data must therefore be acquired at a 
certain point of the cardiac cycle. The traditional approach is to 
image during diastasis, as this is the period in the cardiac cycle when 
the myocardium is most at rest. Diastasis occurs during mid to-late 
diastole and its length is inversely related to heart rate.  
In multi-phase acquisitions, multiple k-spaces are acquired 
throughout the R–R interval. After inverse Fourier transformation 
this produces a multi-frame cine of cardiac motion. The easiest way 
to perform cine MRI is prospective gating. This can be understood by 
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considering single-phase techniques in which data is acquired in a 
certain part of the cardiac cycle. If the trigger delay was set at 0 ms 
the single-phase technique would only acquire the first part of the 
cardiac cycle (Fig. 4). However, if data acquisition was continued 
another segment would be acquired and a second k-space would be 
filled in the same number of R–R intervals. Obviously this would 
represent the second frame in the cardiac cycle. Consequently, if data 
was acquired during the whole R–R interval, one could produce a 
multi-phase cine loop of cardiac motion. In multi-phase sequences, 
the number of frames acquired depends on the time it takes to fill a 
segment (i.e. the line per segment). As the lines per segment go up, 
the number of frames is reduced and thus the temporal resolution 
falls. However if the lines per segment go down (improving the 
temporal resolution) the acquisition times goes up. Thus, in multi-
phase imaging there must be a compromise between temporal 
resolution and acquisition time.  
 
Fig. 4 Prospective multi-phase acquisition. In this example, k-space is divided 
into four segments—each of which is collected at the same point in the cardiac 
cycle in four R–R intervals. Each k- space is collected at a different point in the 




End diastole can be imaged if retrospective gating is used (Lenz et al. 
1989). In retrospective gating, lines in k-space are continuously 
collected during the scan. Each line in k-space is then time stamped 
in relation to the R–R interval it is acquired in. At the end of the scan 
the average R–R interval is calculated and each individual R–R 
interval is stretched or compressed to this mean value. This 
deformation can either be done in a linear manner or in more 
complex ways in which diastole is stretched more than systole. The 
end result of this temporal deformation is that all lines in k-space are 
time stamped relative to the mean R–R interval. They can then be re-
binned (in simplistic terms) to produce separate frames. Unfortu- 
nately complete filling of k-space requires a certain amount of 
redundancy, and therefore in retrospective gating more lines are 
sampled. Thus, retrospective gating has the advantage of imaging 
throughout the cardiac cycle, although at the cost of slightly longer 
scan durations.  
Not only cardiac motion but also respiratory motion would cause 
significant artefacts if not taken into consideration. The simplest 
method of dealing with breathing is to perform imaging during breath 
holds. Increasing either spatial or temporal resolution will lead to 
prolonged breath hold times. In longer imaging sequences such as 
gated whole heart MR angiography, the above-mentioned strategies 
have little chance of success. These longer acquisitions need a 
different approach to respiratory motion compensation such as 
respiratory navigators (Keegan et al. 1999). Fundamentally these are 
simple MR measurements of diaphragmatic position that enable data 




Imaging Planes for Cardiac Structures  
	
The transverse or axial plane (Fig. 5) is useful for studying 
morphology and the relationships of the four cardiac chambers and 
the pericardium. These images are appropriate for evaluation of the 
overall morphology of the heart but quantitative measurements of 
wall thickness, cavity dimensions and functional data cannot be 
obtained accurately since the planes are not perpendicular to the wall 
or the cavity (Longmore et al. 1985). Therefore the cardiac imaging 
planes are more suitable for this purpose. To obtain the correct 
inclinations for imaging in the cardiac axes, a transverse or axial 
scout view at the level of the left ventricle (LV) is acquired initially 
(Burbank et al. 1988). On this image, a new plane is chosen running 
through the apex of the LV and the middle of the left atrioventricular 
(AV), mitral valve. This yields the vertical long-axis (VLA) plane 
(Fig.6b). On this image, a plane chosen to transect the LV apex and 
the middle of the mitral ring yields the horizontal long-axis (HLA) 
plane (Fig.6c). The short-axis (SA) plane can now be prescribed 
perpendicular to both the VLA and HLA (Fig.6d). From a SA plane 
at the level of the mitral valves, the four-chamber view can be 
acquired (4Ch). The plane for the 4Ch view passes from the most 
superior mitral valve,‘‘anterolateral’’ papillary muscle to the inferior 
angle of the right ventricle (RV) anteriorly, usually through the mid-
point of the interventricular septum (Fig.6e). A true-SA plane can 
now be prescribed off the 4Ch view perpendicular to the 

















Fig 6. Cardiac axis imaging planes for the left ventricle, images acquired using a 
SSFP sequence. The vertical long-axis plane (VLA) (b) is aligned from the axial 
plane (a) through the mitral valve and the LV apex, which may be on a separate 
more inferior slice. The horizontal long-axis plane (HLA) (c) is aligned from the 
VLA through the mitral valve and LV apex. The short-axis plane (SA) (d) is 
aligned from the VLA and HLA planes—perpendicular to both. The 4-chamber 
plane (e) is aligned from the SA through the anterior mitral valve papillary 











Fig. 7 Alignment of SA stack for analysis of ventricular volumes on the HLA. 
Note that the basal slice is parallel to the atrioventricular (AV) valves (between 




From the SA plane the VLA (2Ch), HLA (4Ch) and LV inflow/ 
outflow (3 Ch) can be acquired (Fig. 8). This later LV inflow/outflow 
image is acquired with a plane that passes across the center of the 
aortic and mitral valves on the basal SA slice. A view of left 
ventricular outflow tract (LVOT) can be acquired by passing an 
imaging plane through and perpendicular to the aortic (Fig.9b). This 
can be easily achieved by indicating on an LV inflow/ outflow image 
a perpendicular imaging plane through the middle of the aortic valve. 
Both the LVOT and LV inflow and outflow planes are well suited for 
evaluation of aortic valve stenosis and/or regurgitation. A plane 
through the aortic root (‘‘aortic valve plane’’), just above the aortic 
valve, perpendicular to both the LV inflow/outflow and LVOT views, 
can be used to assess through-plane aortic flow. This plane is used 
when quantifying aortic incompetence (Fig.9). The morphology of 
the aortic valve (e.g., number of valve leaflets and fusion of leaflets), 
aortic valve area and orifice can be best studied in this plane using a 




















Fig. 8 Imaging planes that can be aligned from the basal SA slice (a): The LV 
inflow (mitral valve)/outflow (aortic valve) view (b), the VLA  (c) and 4-chamber 












Fig. 9 Alignment of the aortic valve plane (c) for aortic flow assessment from the 
LV inflow/outflow (a) and the left ventricular outflow tract (LVOT) (b) views 
(dotted lines). The imaging plane should be placed just above the aortic valve, 
yet just below the origin of the coronary artery origins. The LVOT view is 
prescribed perpendicular to the LV inflow/outflow view (complete line on (a) 
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The mitral valve lies in a double oblique plane. Through-plane 
imaging of the mitral valve to assess LV inflow curves should 
therefore be aligned from two views, the VLA and 4Ch (Fig.10). For 
flow measurements, the plane should lie just beyond the mitral valve 









Fig.10 Alignmentof the tricuspid valve plane (c) for RV inflow assessment from 
the VLA (a) and the 4- chamber planes (b). The imaging plane should be placed 
just within the RV 
 
Right Heart  
A two-chamber view of the right heart can be obtained by placing a 
plane through the RV apex and the mid-point of the tricuspid valve 
on the 4Ch view. The right ventricular outflow tract (RVOT) is 
visualized by aligning a plane that passes through the main 
pulmonary artery (PA) and the RV inferiorly from a set of axial 
images (Fig.11c). A plane perpendicular to this, in an axial or oblique 
axial orientation, will give a second view through the RVOT 
(Fig.11d). A plane through the main PA, just above the pulmonary 
valve, perpendicular to both RVOT views, can be used to assess 
through-plane pulmonary flow. This plane is used when quantifying 
pulmonary incompetence (Fig.11e).  As with the mitral valve, the 
tricuspid valve lies in a double oblique plane. Through-plane imaging 
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of the tricuspid valve to assess RV inflow curves should therefore be 
aligned from two views, the RV 2 chamber view and 4Ch view. For 
flow measurements, the plane should lie just beyond the tricuspid 










Fig. 11 Alignment of the pulmonary valve plane (e) for pulmonary flow 
assessment from two perpendicular right ventricular outflow tract (RVOT) (c and 
d) views (dotted lines). The imaging plane should be placed just above the 
pulmonary valve. The first RVOT view is prescribed from an oblique plane 
through the main pulmonary artery and RV on a set of axial images (a and b). 
The second RVOT plane is prescribed perpendicular to the first RVOT view 
(complete line on (c) 
 
Main sequences in CMR 
	
There are two fundamental types of sequence commonly used in 
CMR: gradient echo (GE) and spin echo (SE).  
The spin echo pulse sequence generates images that have intrinsic 
black blood contrast. This is because it uses two pulses, the 90° and 
180° RF pulses. The transverse magnetisation of blood flowing 
through the slice that moves out of the slice between the two pulses is 
not refocused by the 180° pulse and does not contribute to the 
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generation of a spin echo. This results in a signal void, also known as 
a ‘black blood’ or ‘dark blood’ appearance. This effect is also known 
as the spin washout effect, referring to the ‘washout’ of proton spins 
form the image slice that would otherwise be refocused and 
contribute to the spin echo signal. Spin echo sequences are mainly 
used for anatomic imaging and tissue characterization. 
In contrast to the spin echo sequence, the gradient echo (GRE) 
sequence only uses one RF pulse to generate the signal and use a 
partial flip angle (less than 90°). A consequence of partial flip angle 
is that there is significant longitudinal magnetization present even 
after a short repetition time (TR). In GRE imaging with a short TR, 
longitudinal magnetization may not fully recover before the next RF 
pulse. Thus, the amount of magnetization able to be flipped back into 
the transverse plane is reduced. However, if the spins are moving (i.e. 
blood moving in the through plane direction) new unsaturated spins 
will be present in the slice during the next excitation. This increases 
the total magnetization available to be flipped into the transverse 
plane, increasing the signal. Thus, structures containing blood 
moving in the through plane direction will appear brighter than 
surrounding stationary tissue. This effect is known as inflow 
enhancement. The gradient echo pulse sequence is therefore 
commonly referred to as a bright blood imaging technique.  
GRE sequences are commonly used to dynamically image the heart. 
The most recent standard cardiac MR sequences are balanced steady-
state free precession (b-SSFP), which provide the best contrast 
between chamber blood (white) and myocardium (dark), and these 
are now routinely used for imaging of cardiac function. 
  
Anatomical MRI  
	
To acquire anatomical images of the heart and major vessels turbo 
spin echo (TSE) pulse sequences are commonly used. The spin echo 
(SE) pulse sequence generates a spin echo signal by the use of an 
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excitation pulse followed by a 180° RF refocusing pulse. The 
turbo/fast spin echo pulse sequence generates multiple echoes by 
applying multiple 180° pulses after the initial 90° pulse. After each 
180° pulse there is a corresponding spin echo. The number of echoes 
acquired for each excitation pulse is known as the echo train length 
(ETL) or turbofactor and this defines the acceleration factor for the 
pulse sequence. Typically echo train lengths of 15 or 16 are used in 
order to reduce the imaging time to within a breath-hold period.  
 
T1-weighted (T1W) and T2-weighted (T2W) MRI 
	
TSE sequences are particularly well suited to T1W and T2W imaging 
that allows evaluating myocardial signal. In cardiac MRI the main 
use of T2-weighted imaging is to perform myocardial edema 
imaging. This is because water has a long T2 and will therefore show 
up more brightly. Usually T2-weighted sequences include a fat 
suppression (Simonetti et al. 1996). A robust method of fat 
suppression is Short Tau Inversion Recovery (STIR) (Simonetti et al. 
1996). Inversion recovery (IR) is the most commonly used form of 
magnetization preparation. IR depends on the fact that different 
tissues have different T1 characteristics. In IR sequences, an 180o RF 
pulse (or inversion pulse) is used to flip the magnetization into the 
opposite direction along the z-axis. From this position the 
magnetization relaxes back to its original state following the T1 
curve of the tissue. As different tissues have different T1 
characteristics, each tissue will pass through zero (or the null point) 
at different times. During RF excitation (which is applied some time 
after the IR pulse) only tissues with non-zero longitudinal 
magnetization will produce an MR signal. Therefore if the time 
between inversion and imaging (TI) is chosen carefully, signal from a 
given tissue can be completely abolished. STIR relies on the short T1 
of fat compared to other tissues. Therefore, the fat magnetization will 
pass through null point of an IR sequence before the tissue of interest. 
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If imaging is performed at the null point of fat, the signal from the fat 
will be suppressed.  
Another method of fat suppression is Spectral Inversion Recovery 
(SPIR). Spectral selective pulses rely on the fact that water and fat 
precess at slightly different frequencies (approximately 220 Hz 
difference at 1.5T). Therefore a special RF pulse can be used that 
only excites fat. In SPIR a spectrally selective 180o pulse is used to 
invert only the fat magnetization. The water magnetization is 
unchanged by the spectrally selective 180o pulse. The fat mag- 
netization is then allowed to recover and a TI is chosen that coincides 
with the null point of fat. Unlike STIR, at the onset of imaging all of 
the water magnetization is in the longitudinal axis and therefore there 
is no loss in signal to noise ratio (SNR).  
Cine MRI 
	
Cine imaging involves the acquisition of data at multiple time points, 
known as a cardiac phases, throughout the cardiac cycle. The trigger 
delay for the first time point is set to the shortest possible time after 
the R wave to enable images to be acquired from the beginning of the 
cardiac cycle. Data acquired within each cardiac phase fills a separate 
k-space, resulting in the reconstruction of a separate image 
corresponding to each cardiac phase. The images for all the cardiac 
phases are then viewed as a movie sequence or cine, allowing 
functional assessment of the heart, its wall motion and a visual, 
qualitative assessment of blood flow. 
Cine imaging requires very short repetition times to be used and 
therefore can only be achieved using gradient echo-based pulse 
sequences. The main type of gradient echo pulse sequence used for 
cine imaging is balanced steady state free precession (bSSFP). B-
SSFP is a GRE sequence that primarily relies on steady-state 
magnetization for signal production. If the TR is short, residual 
transverse magnetization will be present during subsequent 
excitations, eventually leading to the evolution of steady state 
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magnetization.  
Phase contrast (PC) MRI 
	
Velocity encoded phase contrast (PC) techniques enable non-invasive 
quantification of blood flow in major vessels or throughout a cardiac 
valve during the heart cycle. PC-MRI utilizes simple spoiled GRE 
sequences combined with an additional velocity-encoding gradient. 
This additional gradient creates a phase image in which pixel 
intensity is directly proportional to velocity (Fig.12). After RF 
excitation all magnetization is coherent and in phase. If a gradient is 
then applied in the z direction, spins in the static tissue will dephase 
depending on their spatial position. Spins in the moving blood will 
also accrue phase, but because they are moving through the gradient 
field they will accrue more (or less depending on the direction of 
flow). So at this point static spins will have phase due to their spatial 
position, while moving spins will develop phase because of their 
position and velocity (Fig.12a). If we now reverse the gradient the 
phase in the static tissue will return to zero. However, the phase in 
the moving blood will not go back to zero, rather it will be more or 
less than zero depending on direction of flow (Fig.12b). This is 
because the spins in the moving blood are continuously traveling 
through a varying magnetic field. The end result of these two 
gradient lobes is that the phase of a spin population is directly 
proportional to their velocity.  
The operator has to set a maximal encoding velocity (Venc). The 
Venc represents the practical upper limit of velocities that can be 
depicted and should ideally be set to a numerical value just greater 
than the true flow velocity. Problems occur if it is set much higher or 
lower than this value – with the former leading to less sensitivity and 





Fig. 12 The phase contrast experiment. A) When a gradient is applied in the 
direction of flow the static tissue dephases; however in this case the moving 
spins diphase more because they are moving into a stronger magnetic field. B) 
When the negative gradient is applied the static spins rephrase, however as the 
moving spins are moving into an even higher magnetic field they are left with 
residual phase at the end of the experiment  
 
Late gadolinium enhancement (LGE) MRI 
	
Late gadolinium enhancement (LGE) imaging allows evaluating the 
signal of the myocardium after intravenous administration of an MR 
contrast medium to differentiate viable myocardial tissue from non-
viable/infarcted myocardial tissue. The contrast agent is based on the 
element Gadolinium. Gadolinium is a highly paramagnetic substance 
that mediates the T1 relaxation time of water molecules when it is in 
close proximity to them. The T1 relaxation time is therefore reduced, 
demonstrated by an increase in signal intensity when using T1-
weighted imaging methods. The contrast agent is carried within the 
blood pool into the myocardial muscle where it enters extra-cellular 
space. Wash-in and wash-out of the contrast is relatively fast for 
normal myocardium, whereas wash-in and wash-out is delayed for 
infarcted muscle. 
Delayed imaging after contrast agent injection using a T1-weighted 
fast gradient echo pulse sequence is able to demonstrate areas of 
infarction as areas with increased signal where there is a greater 
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concentration of contrast agent. Inversion recovery preparation 
schemes are combined with fast gradient echo pulse sequences. The 
inversion recovery (IR) technique provides T1-weighting and 
enhances the signal difference between normal and infarcted 
myocardium by suppressing the signal from normal myocardium 
(Fig.13). Contrast-enhanced inversion recovery relies on the fact that 
tissue containing gadolinium will have a shorter T1 than tissue not 
containing gadolinium. It is known that gadolinium (Gd) 
concentration in infarcted myocardium is higher than in normal 
myocardium. Therefore by the time the magnetization from the 
normal myocardium passes through the null point of an IR sequence, 
the infarcted myocardium will already have regained positive 
longitudinal magnetization. Consequently, if the inversion time (TI) 
is chosen to coincide with myocardial nulling, infarcted tissue will 
appear bright (Fig. 13c).  
The use of the fast gradient echo pulse sequence allows image 
acquisition to be kept within a breath- hold period. The images are 
collected 10-15 minutes after the injection, hence the name late 
gadolinium enhancement, abbreviated LGE (previously delayed 
enhancement). Timing of the image acquisition is of paramount 
importance as too early image acquisition reduces the difference in 
contrast between normal and damaged myocardium (i.e., myocardial 
scar, fibrosis) because of insufficient washout of contrast from the 
normal myocardium, while too late image acquisition can result in an 
excessive washout of contrast from damaged myocardial tissue. 
 The quality of LGE imaging depends on the effective suppression of 
the signal from normal myocardium. This requires very precise 
selection of the appropriate inversion time, TImyocardium, which 
depends on many factors, including the dose of contrast, the delay 
after administration and the rate of renal excretion. The TI is 
therefore chosen by performing a number of fast, low-resolution test 
image acquisitions at different TIs, typically within the range from 
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200–250 ms in steps of 25–50 ms. The TI from the test image that 
demonstrates the best suppression of normal myocardium is then 
used to perform imaging at full resolution. This can also be achieved 
by performing a so-called TI-scout, which acquires images at 







Fig 13. Late Enhancement imaging is performed using an inversion recovery fast 
(or turbo) gradient echo pulse sequence (a). The fast (or turbo) gradient echo 
pulse sequence allows the image acquisition to be completed within a few heart 
beats. Image acquisition is normally per- formed in diastole to minimise the 
effects of heart motion. The 180° inversion pulse is followed by a delay, TImyocardium, 
selected to suppress the signal from normal myocardium. The graph in (b) shows 
the relaxation curves for normal myocardium, the blood pool and scar tissue. The 
higher concentration of contrast agent within scar tissue results in a faster T1 
relaxation rate and therefore an increased signal compared to the blood pool and 
normal myocardium. Nulling the signal from normal myocardium maximises the 
scar tissue contrast. The image in (c) shows the enhanced signal from scar tissue 
(small black arrows), and the nulled signal within the normal, viable myo- 




LGE imaging provides high spatial resolution, high contrast images, 
making CMR the non-invasive gold standard for identifying 
infarction/replacement fibrosis. In coronary artery disease (CAD), 
CMR identifies smaller infarcts routinely missed by lower resolution 
modalities (eg, SPECT) (Wagner et al. Lancet 2003). Ischemic 
cardiomyopathy is characterized by areas of scarring that typically 
involve the subendocardium, and depending on the size of the infarct, 
extend up to the epicardium in a pattern consistent with the “wave 
front phenomenon” of ischemic cell death (Fig. 14) (Reimer et al. 
Circulation 1977). Infarct assessment is pivotal in guiding patient 
selection for revascularisation (those with viable myocardium) and 
predicting adverse outcome (Kim et al N Engl J Med 2000).  The 
transmural extent of LGE predicts functional improvement following 
revascularisation: recovery is more likely in segments with ≤50% 
transmural infarction than those with ≥75% (Kim et al. N Engl J Med 
2000). Viability assessment with CMR has the advantage of 
obviating pharmacological stress. However, an important caveat is 
that it may overestimate infarct size in the acute phase (2–3 weeks) of 
acute coronary syndromes (ACSs), as reversible oedema increases 
gadolinium uptake (Mather et al. Radiology 2011). In ACS, LGE 
imaging also detects microvascular obstruction, a strong predictor of 
adverse remodelling and unfavourable prognosis (Khan et al. World J 
Cardiol 2017;). Extensive microcirculatory damage, thrombosis and 
oedema-related vessel compression delay gadolinium-based contrast 
agents penetration into the infarct core, manifesting as a 
characteristic central black zone surrounded by hyperenhancement 
(Mather et al. Journal of Cardiovascular Magnetic Resonance 2009). 
‘Early’ gadolinium imaging is useful for identifying thrombus 
(ventricular/atrial): early after contrast administration, when the 
blood pool remains bright, avascular thrombus appears as a dark 
filling defect (Srichai et al. Am Heart J 2006). 
In non-ischaemic disease, the pattern/distribution of LGE may offer 
clues regarding aetiology and prognostic significance (Fig.14). 
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Myocarditis typically causes subepicardial/midmyocardial scarring, 
usually (though not always) in a non-coronary distribution with 
subendocardial sparing. A diagnosis of non-ischaemic dilated 
cardiomyopathy (DCM) may be confirmed by midwall fibrosis, a 
recognised risk factor for cardiac death, ventricular arrhythmia and 
heart failure hospitalisationn (Lehrke et al. Heart 2011). LGE 
imaging may also prove instructive in hypertrophic states. In 
hypertrophic cardiomyopathy (HCM), collagen deposition and fibre 
disarray may cause patchy, midwall (sometime diffuse) LGE, even 
when overt hypertrophy is absent (Rudolph et al. J Am Coll Cardiol 
2009). In HCM, LGE is a risk factor for ventricular arrhythmia and 
sudden cardiac death (SCD) (Briasoulis et al. Heart 2015). Diffuse 
fibrosis is also found in hypertensive heart disease and aortic stenosis 
(though usually less pronounced) (Rudolph et al. J Am Coll Cardiol 
2009). In Anderson-Fabry disease (an X-linked lysosomal storage 
disorder), LGE has an inferolateral midmyocardial predilection 
(Moon et al. J Cardiovasc Magn Reson 2006). In cardiac 
amyloidosis, global diffuse enhancement is characteristically seen 
with a dark blood pool: amyloid fibrils avidly bind GBCA, with 
consequent difficulty nulling the myocardium. The presence of LGE 
is correlated with adverse prognosis (Fontana et al. Circulation 2015). 
Global subendocardial enhancement is also seen in small-vessel 
vasculitides and endomyocardial fibrosis (eg, hypereosinophilic 
disease), with the pathognomonic ‘apical V sign’. Cardiac sarcoidosis 
is associated with multiple foci of patchy enhancement, which are 
predictive of mortality and ventricular arrhythmia (Coleman et al. 
JACC Cardiovasc Imaging 2017). The presence of mediastinal 
lymphadenopathy should be sought, as its absence makes this 
diagnosis unlikely. LGE imaging may also identify atrial 
scarring/fibrosis (amyloid and atrial ablation). In arrhythmogenic 
cardiomyopathy (AC), LGE may be present in regions of fibrofatty 





Fig. 14. LGE Patterns for Ischemic and Nonischemic Disorders. A schematic 
representation of hyperenhancement (HE) patterns that are characteristic for 
ischemic and nonischemic disorders. Note that the area of HE in ischemic 
cardiomyopathy always involves the subendocardium. In contrast, midwall or 





Ventricular Morphology and Function by CMR.  
	
CMR is regarded as the “gold standard” for quantifying ventricular 
volume, mass, structure and function. Impressive results for accuracy 
have been demonstrated by several investigators in various disease 
states (Boxt et al. J Am Coll Cardiol.1992; Suzuki et al. Am Heart J. 
1991). The interstudy reproducibility of CMR-derived parameters of 
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ventricular function and mass is good for both the left and right 
ventricle and is superior to two-dimensional and M mode 
echocardiography (Bottini et al. Am J Hypertens 1995; Semelka et al. 
Radiology1990). 
Ventricular volumes, ejection fraction, and myocardial mass are 
obtained from a post precessing analysis (Fig. 15) on cine CMR 5-
10mm slices covering the LV and RV acquired in short. Endocardial 
and epicardial contours are drawn during post processing on end-
diastolic and end-systolic frames, and LV and RV volumes are 
calculated as the sum of individual slice volumes. Tracing of the end-
diastolic LV epicardial borders in addition to the endocardial borders 
allows determining LV mass. A previous criticism of this technique 
has been the time required to analyse the cine data to generate 
accurate volume and mass data. New software solutions with 
intensity based thresholding for semiautomated myocardial-blood 














 Phase contrast velocity mapping is an MR sequence used to measure 
velocity and flow in blood vessels, or within the heart, in which each 
pixel in the image displays the signal phase, which is encoded. 
Quantification of volume flow requires acquisition of a short axis 
view of a vessel with blood flow in the through plane direction. The 
phase map of such a slice can be used to calculate the average spin 
velocity in each pixel (vpix) at time t. The pixel area multiplied by 
vpix is the volume flow in each pixel (Qpix) at time t. The sum of 
Qpix within a region of interest (ROI) drawn around the vessel equals 
the volume flow at time t (Fig. 16). As phase measurements are made 
at multiple time points within the cardiac cycle forward flow, 
regurgitant flow and cardiac output can then be calculated. This 
imaging technique has been available for over 20 years (Nayler et al. 
J Comput Assist Tomogr 1986). Velocity encoded imaging has been 
shown to be a reliable method to measure blood flow in different 
vessels of the body. Analogous to Doppler echocardiography, this 
technique allows the calculation of stroke volume, cardiac output, 
ejection fraction, valvular regurgitant fractions, and quantification of 
cardiac shunts, while mitral and tricuspid transvalvular flow profiles 
allow the assessment of ventricular diastolic filling patterns. Cardiac 
output and the pulmonary-to-systemic flow ratio (Qp:Qs) measured 
with the use of this technique have been shown to be accurate 
(Beerbaum et al. Circulation 2001; Robertson et al. Magn Reson 
Imaging 2001). Phase contrast MR flow is less accurate in patients 
with either cardiac arrhythmia during acquisition or turbulent blood 









There is increasing evidence that the underlying, pathological basis 
for a variety of non-ischemic cardiomyopathies is myocardial 
fibrosis. This pathological process of extracellular matrix (ECM) 
remodeling results in multiple functional consequences including 
impaired relaxation (Sugihara et al. J Cardiol  1988), precipitation of 
arrhythmias (Ling et al. J Am Coll Cardiol  2012) and impaired 
contractile reserve (McLenachan et al. Am J Hypertens  1990). 
Traditionally, myocardial fibrosis has been recognized in conditions 
such as hypertensive heart disease, HCM and idiopathic dilated 
cardiomyopathy (DCM). However, there is increasing identification 
of myocardial fibrosis as the common causative factor of myocardial 
dysfunction in many other, particularly metabolic, processes such as 
obesity, diabetes and aging. Early identification of this underlying, 
often diffuse, interstitial myocardial fibrosis is important for 
diagnosis and essential for optimization of reversibility with 
intervention. Late gadolinium enhancement (LGE-CMR) imaging has 
become the new gold standard for identification of focal brosis. T1 
mapping has the potential to provide a similar quantitative 
assessment of diffuse myocardial fibrosis.  
In general, methods for measuring myocardial T1 consists of three 
components: 1) a perturbation of the longitudinal magnetization 
(based on inversion or saturation recovery), 2) an experiment to 
sample the relaxation curve as the longitudinal magnetization returns 
to its original level, and 3) a model used to fit the sampled curve and 
extract the myocardial T1.  
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Multiple CMR T1 based techniques have been employed for 
quantitation of diffuse fibrosis. The original scheme known as the 
MOdified Look-Locker Inversion Recovery (MOLLI) proposed by 
Messroghli, et al. (Messroghli et al. Magn Reson Med 2004) is 
illustrated in Figure 17. For each inversion, the MOLLI method 
samples the IR curve at multiple inversion times using single shot 
imaging spaced at heart beat intervals. Multiple inversions are used 
with different trigger delays in order to acquire measurements at 
different inversion times to sample the IR curve more evenly. 
Recovery periods are needed between the inversions to ensure that 
samples from the different inversions are from the same recovery 
curve, i.e., each inversion starts at the same initial magnetization. The 
T1-map precision is related to the number and position of samples 
along the IR curve, and accuracy of the signal model is also affected 
by the sampling strategy due to the influence of the readout on the 
apparent recovery. 
MOLLI technique was designed to overcome the limitations of 
motion and prolonged acquisition time. Specifics included an ability 
to acquire data within one breath-hold at a designated time within the 
cardiac cycle and the capability of merging images from multiple 
Look Locker experiments at different consecutive inversion times 
into one data set. MOLLI sequencing employs a balanced steady-
state free precession (SSFP) readout to achieve a higher signal to 
noise ratio with a narrow image acquisition period of less than 200 
msec in end-diastole to minimize motion artifact. Reproducibility of 
this technique is high (Messroghli et al. Radiology 2006).  
Even faster acquisition times have been achieved by Piechnik et al. 
who developed a shortened MOLLI sequence (ShMOLLI) which 
requires a short breath-hold of only nine heart beats duration 
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(Piechnik et al. J Cardiovasc Magn Reson 2010). Both sequences are 
similar but ShMOLLI does not require full recovery of magnetization 
on sequential inversion pulses and has less heart rate (HR) 
dependency, which may improve accuracy (Messroghli et al. J Magn 
Reson Imaging 2007).  
 
 
Fig. 17 MOdified Look-Locker Inversion Recovery (MOLLI) scheme for T1-
mapping in the heart. The original protocol employed 3 inversions with 3, 3, and 
5 images acquired in the beats following inversions, and 3 heart beat recovery 
periods between inversions, referred to here as 3(3)3(3)5. All images are 
acquired at the same delay from the R-wave trigger for mid-diastolic imaging. 




Typically a series of short-axis images are acquired pre- and 
approximately 12 minutes after gadolinium-based contrast with 
between 6 and 12 consecutively longer inversion times depending on 
the protocol. Offline, standard basal, mid-ventricular and/or apical 
slices are then selected and can be further divided into conventional 
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myocardial segments (or discrete regions of interest) and blood-pool 
for analysis if desired. A curve fitting technique is employed to 
reconstruct the consecutively acquired images into one data set from 
which a T1 map of voxels is generated. The signal intensity of each 
mapped voxel directly represents the T1 relaxation time of the 
corresponding myocardial tissue. An exponential recovery curve of 
signal intensities at the different inversion times is then created for 
each designated region of interest (slice or segment) to determine the 
myocardial T1 relaxation time.  
The ratio of myocardial to blood post-contrast T1 values is expressed 
as the partition coefficient. By preceding post-contrast T1 mapping 
with pre-contrast T1 mapping, myocardial extra-cellular volume 
(ECV) can similarly be derived. This pseudo-equilibrium technique 
employs the reciprocals of myocardial and blood T1 values pre- and 
post-contrast and then adjusts for hematocrit to correct for the blood 
contrast volume of distribution (Messroghli  et al. Circ Cardiovasc 
Imaging 2011;  Ugander  et al. Eur Heart J 2012). This ECV is 
expressed as a percentage of the total myocardial extracellular space. 
A larger ECV represents increased contrast accumulation in an 




Fig. 18 Pre- and post-gadolinium (Gd) contrast dispersion in normal versus 
fibrotic myocardium.  
 
Pre-contrast T1 mapping  
	
Pre-contrast techniques measure the intrinsic or native myocardial 
T1. They have an inherent advantage for subjects with significant 
renal impairment who may be at increased risk of nephrogenic 
systemic sclerosis. However, non-contrast T1 mapping is limited by 
an inability to clearly distinguish interstitial from myocyte signal 
intensity. This may be of clinical consequence in early disease 
processes when there is minimal difference in T1 values between 
healthy and disease states. Standardization of the acquisition phase in 
the cardiac cycle within and between studies remains an important 
consideration as acquisition timing can impact on T1 value and ECV 
due to fluctuation of the myocardial blood volume (Kawel  et al. J 
Cardiovasc Magn Reson 2012). A reduction in T1 time of 43-70% 
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has been observed from diastole to systole (Wansapura  et al. Magn 
Reson Imaging 2006). Clinical feasibility of T1 mapping markedly 
increased with the advent of non-contrast MOLLI imaging due to 
increased reproducibility, higher spatial resolution and reduced 
motion artifact. However, this technique remains prone to frequency-
dependent errors in T1-measurement (Kellman et al. J Cardiovasc 
Magn Reson 2013). 
Post-contrast T1 mapping 
	
Post-contrast techiniques measure T1 time after gadolinium-based 
contrast injection. There is a distribution difference of contrast 
between normal and fibrotic myocardium (Fig.18). Areas of fibrosis 
demonstrate greater gadolinium accumulation, which is represented 
as a region of high intensity signal with a shorter T1 time than 
adjacent normal tissue (Dulce et al. AJR Am J Roentgenol 1993). In 
addition to heart rate and acquisition related confounders, there are 
several established physiological covariates related to contrast 
administration, which must be considered. These include: body fat 
percentage, renal function, delay time in measurement after contrast 
administration and gadolinium characteristics (such as dose, 
concentration and water exchange rate).  
Partition coefficient and ECV mapping  
 
Estimation of partition coefficient and ECV fraction from T1 
mapping reduce the effect of confounding variables as they are 
calculated from the ratio of change in myocardial T1 relative to 
blood-pool T1 pre and post-contrast (Jerosch-Herold  et al. Am J 
Physiol Heart Circ Physiol 2008). The advantage of this type of 
methodology is that it minimizes systematic errors in technique, 
enables better comparison of scans at different time points and results 
in less variability at different field strengths and across different 
vendor platforms. This could be of significant clinic benefit for 
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monitoring of interval change within individuals, assessing treatment 
effect and allowing comparison of disease patterns within the general 
community. The main confounding factor affecting the partition 
coefficient is hematocrit. However, it can be easily corrected using 
blood volume of distribution (1-hematocrit) to give the ECV. 
Although the ECV is a more reliable measure of interstitial space, it 
remains based on the assumption of contrast equilibrium between 
blood and myocardium. Clinically, there is a wide spread of ECV 
values with overlap of values between normal and diseased 
myocardium (Kawel  et al. J Cardiovasc Magn Reson 2012). This 
makes it problematic for diagnostic purposes and more suited to 
measurement of interval change within individuals or assessment of 
more end-stage disease.  
Normal ECV values of 25.3 ± 3.5% [1.5 T] have been reported in 
healthy individuals (Sado et al. Heart 2012) (Fig.19). Apart 
from amyloid, an increased ECV is most often due to 
excessive collagen deposition and is thus a more robust measure of 
myocardial fibrosis. Low ECV values occur 
in thrombus and fat/lipomatous metaplasia. ECV can either be 






Fig. 19 Tissue characterisation using native T1 and extracellular volume fraction 
(ECV). Absolute values for native T1 depend greatly on field strength (1.5 T or 3 
T), pulse sequence (MOLLI or ShMOLLI), scanner manufacturer and rules of 
measurements. For the purpose of comparability, only studies using 1.5 T 
scanners were considered in this figure.  
 
T2 and T2* mapping 
Myocardial T2 mapping is a technique used to reconstruct a 
parametric image based on the T2 value measured in each voxel. The 
accumulation of water in the myocardium is associated with different 
types of pathology, such as acute myocardial infarction, myocarditis 
and graft rejection. Given a long transverse relaxation time of water 
protons, myocardial T2 mapping appears to be promising to detect 
intramyocardial water and even quantify myocardial edema.  
T2* relaxation refers to the rapid decay of transverse magnetization 
caused by local magnetic field inhomogeneity. Magnetic field 
inhomogeneity comes from the inhomogeneity of the static magnetic 
field or from the differences in magnetic susceptibility between 
neighboring tissues, such as air-tissue interfaces, metallic implants, 
paramagnetic contrast agents or iron deposition. Specifically, 
myocardial T2* mapping is sensitive to tissue iron content, and so it 
is widely used to quantify the degree of iron deposition in the 
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myocardium in patients with thalassemia major and repeated blood 
transfusion. 
 
Indications for CMR  
	
CMR has excellent spatial resolution, due to the various sequences 
used, and has excellent anatomical definition. This, combined with 
the lack of interference by body habitus that echocardiography is 
subject to, make it the current gold-standard for assessment of cardiac 
structure, size and function. Furthermore, with the assessment of T1 
and T2 signal and LGE images, CMR is able to characterize the 
myocardium beyond any other non-invasive imaging modality. 
Therefore, CMR has become a highly versatile imaging modality 
with a wide range of clinical indications. These range from 
assessment of congenital heart disease to the phenotyping of 
cardiomyopathies, diagnosis of and risk stratification in ischaemic 
heart disease and vascular applications. Clinical indications for CMR 
have been appraised by European and North American societies 
(Pennell et al. 2004; ACCF/ACR/AHA/ NASCI/SCMR 2010) and 
several international practice guidelines include CMR (Fig. 20).  
 
Fig. 20 Common indications for CMR. DCM, Dilated cardiomyopathy; HCM, 
hypertrophic cardiomyopathy; ARVC, arrhythmogenic right ventricular 
cardiomyopathy; MI, myocardial infarction. 
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Myocardial ischemic disease 
Myocardial infarction (MI) is defined as myocardial cell death 
secondary to prolonged ischemia that results in an inadequate supply 
of oxygenated blood to an area of the myocardium, particularly when 
ischemia exceeds a critical threshold that overwhelms cellular repair 
mechanisms. MI is typically caused by luminal thrombosis 
superimposed on coronary atherosclerosis; occasionally, it can be 
caused by coronary spasm, coronary embolism, or thrombosis in 
nonatherosclerotic vessels. Arteritis, dissection, congenital 
abnormalities, hypercoagulable states, and cocaine use are 
uncommon causes.  
CMR imaging plays an important role in evaluating the various 
stages of MI. The infarct progresses like a “wave-front” from the 
endocardium to the epicardium. Complete necrosis takes 2–4 hours 
or longer, depending on the presence of collateral circulation, 
persistent or intermittent coronary arterial occlusion, sensitivity of 
myocytes to ischemia, preconditioning, and individual demand for 
myocardial oxygen and nutrients. An infarct is termed microscopic 
when <10% of the myocardium is involved, moderate when 10%–
30% is involved, and large when >30% is involved. Transmural MI 
affects the full thickness of affected muscle segments, from 
endocardium through midmyocardium to epicardium. Delayed-
enhancement imaging is the most important technique for evaluation 
of MI. It is the most accurate method for diagnosing MI or 
nonischemic cardiomyopathies, quantifying the scar, assessing 
viability, and evaluating thrombus (Hunold et al. Am J Roentgenol 
2005). In MI, T2-weighted imaging is most useful for detecting the 
presence of edema, which is a marker of acute ischemic injury and 




In acute MI (AMI), regional wall-motion abnormalities of the 
affected vascular territory can be seen on cine images. T2-weighted 
images show wall thickening and myocardial edema. If there is 
irreversible damage, hyperenhancement can be seen on LGE images 
along the distribution of the involved coronary artery due to myocyte 
death, membrane disintegration or rupture, and intracellular entry of 
gadolinium. If the myocardial damage is partial, subendocardial 
hyperenhancement can be seen on LGE images, but if the ischemia 
continues, necrosis gradually progresses outward to involve the 
epicardium, with ensuing transmural delayed hyperenhancement. 
Microvascular obstruction may be present and can be seen as a dark 
non-enhancing area within the enhancing scar on delayed-
enhancement images (Tarantini et al. J Am Coll Cardiol 2005). 
Perfusion defects can be seen on rest perfusion images in regions of 
recently infarcted myocardium. 
 
Chronic MI 
In established chronic MI (CMI), cine images show wall thinning and 
regional wall-motion abnormalities in the affected territory. Edema is 
not seen on T2-weighted images. LGE images show wall thinning 
and subendocardial or transmural delayed hyperenhancement in a 
vascular distribution. Perfusion defects may be seen on both rest and 
stress perfusion images, depending on the degree of transmurality of 




Myocardial non ischemic disease  
Myocardial non ischemic disease include several disorders, such as 
DCM, HCM, cardiac sarcoidosis, stress cardiomyopathy, and others, 
but often show similar clinical presentations which lead to 
progressive heart failure, a high risk of fatal arrhythmias, and a high 
mortality rate. Myocardial non ischemic disease has been 
traditionally diagnosed noninvasively with chest roentgenography, 
standard 12-lead electrocardiography (ECG), transthoracic and/or 
transesophageal echocardiography and nuclear imaging, and 
invasively with coronary angiography, left ventriculography, and 
endomyocardial biopsy. Recent advantage of CMR has enabled us to 
assess cardiac morphology, function and tissue characteristics both in 
ischemic and non-ischemic disease. Thus, CMR can identify cardiac 
abnormalities not readily recognized by conventional imaging 
modalities. Moreover, the LGE sequences give important information 
on differential diagnosis, clinical features, and prognosis (Fig. 14) 
(Satoh et al. World J Cardiol 2014). 
 
Dilated cardiomyopathy 
DCM is the most common isoform of myocardial non ischemic 
disease and is characterized by dilatation of LV chamber and systolic 
dysfunction, which leads to progressive heart failure, high risk for 
fatal arrhythmias and high mortality rate. Although over the half of 
cases are idiopathic, DCM is not a single tree of disease spectrum but 
may include several undetermined etiologies, such as chronic 
myocarditis, tachycardia-induced cardiomyopathy, undiagnosed. 
CMR represents the gold standard technique in quantifying volumes 
and ejection fractions of both ventricles, and with its high 
reproducibility it is suitable in monitoring any changes in cardiac 
	 59	
function over time (Anand et al. Indian Heart 2016). In cine-CMR, 
all cardiac chambers are enlarged and a decrease in LV ejection 
fraction (EF) is evident. The LV wall thickness is normal or 
decreased, but relatively homogenous. In LGE-CMR, DCM has been 
shown to demonstrate mostly a lack of LGE or the presence of mid-
wall enhancement, and a fewer part of cases shows patchy or diffuse 
striated LGE. The distribution of LGE is unrelated to a particular 
coronary arterial territory and corresponds to focal fibrosis at 
autopsy. The mechanisms of myocardial fibrosis in DCM are 
complex and include inflammation, genetic predisposition, micro-
vascular ischemia, and neurohumoral changes. Late-enhancement 
imaging can supply important prognostic information about the risk 
of death and major cardiovascular events (Satoh et al. World J 
Cardiol 2014).  
 
Hypertrophic cardiomyopathy 
HCM is a relatively common genetic disorder of the cardiac 
sarcomere, characterized by an idiopathic LV hypertrophy and affects 
between 0.1 and 0.2% of the population; furthermore, it is the most 
frequent cause of sudden death among the young population.  
Typically, this disorder demonstrates asymmetric septal hypertrophy, 
but can also present atypical patterns of hypertrophy involving the 
mid-ventricle and apex. Hence, HCM has a wide variety of 
morphological, functional, and clinical features.  
Frequently found electrocardiographic alterations are electrical signs 
of left ventricular hypertrophy (high voltage QRS, left axis deviation, 
etc.), ventricular repolarization abnormalities, and pathological Q 
waves. The diagnosis of hypertrophic cardiomyopathy can be made 
through echocardiographic and echo-Doppler examinations, which 
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can detect left ventricular wall thickening (diastolic thickness 15 
mm). Echocardiography also accurately documents the diastolic 
dysfunction associated with the cardiomyopathy and any dynamic 
obstruction of ventricular outflow caused by anomalous movements 
of the anterior leaflet of the mitral valve. Although transthoracic 
echocardiography has been the standard tool for the diagnosis of 
HCM, it has limitations for precise visualization of whole ventricles 
and quantification of hypertrophy. CMR is capable of identifying 
regions of LV hypertrophy not readily recognized by 
echocardiography, especially for apical hypertrophy and apical 
aneurysm, such as the right ventricle in cases of biventricular 
involvement (Anand et al. Indian Heart 2016). 
Furthermore, CMR is considered the gold standard for the 
measurement of ventricular mass. 
In concentric forms of hypertrophic cardiomyopathy, the use of CMR 
is fundamental to make the differential diagnosis from other types of 
cardiomyopathy with a clinically similar presentation, such as non-
compaction cardiomyopathy or storage cardiomyopathies: these 
include the ones occurring in cardiac amyloidosis and Fabry’s disease 
in which there are specific late-enhancement patterns different from 
those typical of hypertrophic cardiomyopathy. This last diagnostic 
criterion, combined with morphological information, justifies the use 
of CMR also in the differential diagnosis of the athlete’s heart 
hypertrophy (Anand et al. Indian Heart 2016). 
The pattern of enhancement most frequently found in hypertrophic 
cardiomyopathy is mesocardial, with a patchy distribution in the 
areas of greatest hypertrophy, most commonly at the anterior and 
posterior RV insertion points, and reflects one of the anatomical 
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substrates of the disease (the disarray that causes expansion of the 
extracellular space) (Satoh et al. World J Cardiol 2014).  
Furthermore, the presence of focal areas of hyperintensity is 
frequently found in the T2-weighted sequences corresponding to the 
hypertrophic myocardium. MR perfusion studies may also supply 
information on ischemic phenomena that reflect microvascular 
damage with possible implications for risk stratification in patients 
with known hypertrophic cardiomyopathy. The presence and extent 
of areas of myocardial fibrosis also seem to be relevant to the 
stratification of risk of arrhythmic events in such patients. CMR is 
also indicated in the follow- up of subjects who have undergone 
surgical treatment, such as subaortic myomectomy, or percutaneous 
alcohol septal ablation. The accuracy of CMR in identifying 
myocardial hypertrophy is useful in family screening (Anand et al. 
Indian Heart 2016).  
 
Arrhythmogenic cardiomyopathy 
 AC is a heart muscle disease clinically characterized by life-
threatening ventricular arrhythmias and pathologically by an acquired 
and progressive dystrophy of the ventricular myocardium with fibro-
fatty replacement. Due to an estimated prevalence of 1:2000-1:5000, 
AC is listed among rare diseases. A familial background consistent 
with an autosomal-dominant trait of inheritance is present in most of 
AC patients; recessive variants have also been reported. AC is a 
major cause of sudden death in the young and in athletes.  
There is no a single gold standard for the diagnosis, which is mainly 
based on functional and structural alterations of the RV, fibro-fatty 
replacement of the myocardium, depolarization and repolarization 
abnormalities, arrhythmias with the left bundle branch block 
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morphology and family history. Genotype-phenotype correlation 
studies have recently identified clinical variants characterized by 
early dominant LV involvement, besides the classical RV variant, 
thus supporting the use of the broader term AC. 
The diagnosis is currently made on the presence of major and minor 
Task Force criteria that include structural, functional, histological, 
electrocardiographic, arrhythmic, and genetic factors.  
CMR can visualize RV wall better than echocardiography. Functional 
abnormalities in cine-CMR include regional wall motion defects, 
focal aneurysms, global RV dilation and dysfunction. In addition, the 
diagnosis could be supported by the presence of fatty infiltration of 
RV or LV free wall that can be suppressed in fat suppression 
sequences (Anand et al. Indian Heart 2016). LGE imaging has been 
shown to provide additional evidence of fibrosis, which often co-




Myocarditis is most commonly caused by a viral infection resulting 
in myocardial inflammation and immune-mediated damage in 
cardiomyocytes. The clinical onset of acute myocarditis may produce 
extremely variable and non-specific signs, including typical “heart 
attack-like” signs (acute chest pain, increased troponin and ST 
segment elevation) and atypical ones including new-onset 
arrhythmias, rapidly evolving dilated cardiomyopathy, and acute 
heart failure. 
The most characteristic features in CMR are the presence of 
myocardial edema, diffuse wall motion abnormalities, subepicardial 
patchy myocardial LGE, and the concomitant involvement of the 
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pericardium. Edema imaging using T2 black blood sequences plays 
an important role in the evaluation of patients with suspected 
myocarditis. The increase in T1 and T2 mapping values also indicate 
the presence of myocardial edema. In particular, T2 mapping seems 
to be a very promising sequence in cases of diffuse myocardial 
edema where focal areas of hyper-intensity are not distinguished 
(Mahrholdt et al. Circulation 2004).  
On LGE-CMR, the subepicardial layer especially in posterolateral 
wall has LGE, and in severe cases, LGE may be more diffuse and 
circumferential (Aquaro et al. J Am Coll Cardiol 2017). 
 
Sarcoidosis 
Sarcoidosis is a systemic granulomatous disease involving the heart 
in up to 50% of cases. Cardiac involvement is characterized by non-
caseous granulomatous infiltration. CMR is proposed as the 
diagnostic investigation in studying the heart of patients with 
sarcoidosis, in the follow-up and assessment of cardiac morphology 
and function and in determining the disease extension. The focal and 
diffuse sarcoid infiltrates, responsible for edema and inflammation, 
are seen as hyperintense areas in T2-weighted sequences with 
saturation of the fat signal. The left ventricular filling pattern and 
changes in contractility can also be studied easily with CMR. Finally, 
analysis of LGE sequences plays a very important role; late 
enhancement seems to localize to the basal parts of the heart, in 
particular in the interventricular septum and the lateral wall, with a 
characteristic distribution (focal or with striae sparing the sub-
endocardium) or, in more advanced cases, with a transmural pattern 
(Komada et al. Nagoya J Med Sci 2016). 
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Fabry’s disease and amyloidosis 
About 4% of patients with a morphological diagnosis of hypertrophic 
cardiomyopathy (on the basis of increased wall thickness) have 
Fabry’s disease. In these patients the activity of α-galactosidase is 
reduced, leading to an accumulation of GL3 glycosphingolipids. In 
many cases, CMR shows an intramyocardial area of late 
enhancement in the basal-lateral wall, an atypical site for 
cardiomyopathy. The reasons for this distribution lie in the increased 
wall stress at this site. Some patients have concentric myocardial 
hypertrophy without LGE and low T1 mapping values, possibly 
related to early stage disease before the onset of myocardial fibrosis. 
CMR can be used to evaluate the efficacy of enzyme replacement 
therapy (Anand et al. Indian Heart 2016). 
Other patients with a morphological diagnosis of myocardial 
hypertrophy show an amyloid restrictive cardiomyopathy 
characterized by diastolic dysfunction, ventricular hypertrophy and 
thickening of the interatrial septum. The distinction from other forms 
of cardiac hypertrophy may be difficult in the early stages of 
amyloidosis. However, the pattern of distribution of the late 
enhancement in amyloidosis is distinctive; widespread, global, and 
mainly subendocardial, with a transmural tendency in more severe 







Quantification of nonviable tissue in Late 
Gadolinium Enhancement 
 
The prognostic role of the Late Gadolinium 
Enhancement 
CMR imaging can be used to comprehensively assess the viability of 
myocardium in patients with ischemic heart disease and to detect 
fibrosis in patients with non-ischemic myocardial disease.  
Since the introduction of primary percutaneous coronary intervention 
(PPCI) for the treatment of acute ST-segment elevation myocardial 
infarction (STEMI), mortality has improved substantially, but the 
morbidity associated with post–myocardial infarct (MI) heart failure 
remains significant. CMR is increasingly being used to quantify MI 
size in randomized controlled trials (RCTs) investigating novel 
cardioprotective therapies targeting myocardial reperfusion injury to 
reduce MI size in patients with STEMI treated with PPCI (Tarantini 
et al. J Am Coll Cardiol 2005). Particularly, the role of LGE in 
infarct myocardial scar visualization and quantification is critical	as it 
is considered the gold standard for MI size quantification. 
Experimental models have shown excellent agreement between size 
and shape in LGE CMR and areas of myocardial infarction by 
histopathology. A strong correlation between the infarction size and 
the functional and hemodynamic alterations following myocardial 
infarction is generally observed and therefore considered a 
fundamental measure in the assessment of the morphological and 
functional consequences of infarction (Kim et al. Circulation 1999). 
MI size, microvascular obstruction (MVO), and myocardial salvage 
assessed by CMR performed in the first few days post-PPCI have all 
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been shown to be strongly prognostic. As a result, CMR is 
increasingly being used for surrogate endpoints in RCTs. A recent 
meta-analysis of 2,632 patients from 10 RCTs found that MI size 
measured by LGE-CMR or single photon computed tomography 
within 1 month post-PPCI showed that for every 5% increase in MI 
size, there was a 20% increase in the relative hazard ratio for 1-year 
hospitalization for heart failure and all-cause mortality (Roes et al. 
Am J Cardiol 2007).  
The presence of scar tissue has an important prognostic and 
therapeutic value as a strong predictor of LV remodeling, cardiac 
dysfunction, appropriate ICD therapy and mortality (Alexandre et al. 
J Cardiovasc Magn Reson 2013). 
Its quantitative analysis is therefore of potential clinical interest and 
relies on the segmentation of the myocardial scar tissue in each 
image, where existing. To this end, several techniques for CMR-LGE 
image segmentation have been previously proposed. The extent of 
the hyper enhancement scar tissue has been shown to be able to 
provide supplementary information beyond conventional risk 
stratification, thus suggesting that quantitative approaches should be 
used to measure scar extent and transmurality (Bondarenko et al. J 
Cardiovasc Magn Reson 2005). 
Infarct size from CMR is also a primary endpoint in many clinical 
trials. Recent studies have also demonstrated how infarct size, shape 
and location from pre-procedural LGE can be useful in guiding 
ventricular tachycardias ablation. These procedures are often time-
consuming due to the preceding electrophysiological mapping study 
required to identify slow conduction zone involved in re-entry 
circuits. Post-processed LGE images provide scar maps, which can 
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be integrated with electroanatomic mapping systems to facilitate 
these procedures (Acosta et al. JACC Cardiovasc Imaging 2018).  
Clinical implementation of these developments necessitates a 
reliable, fast, reproducible and accurate segmentation of the infarcted 
region. Moreover, as use of LGE- based infarct volume estimation 
becomes more clinically relevant, standardization will facilitate more 
consistent interpretation (Bondarenko et al. J Cardiovasc Magn 
Reson 2005). 
It was demonstrated that LGE is associated with frequency and 
occurrence of arrhythmias in patients with HCM (Moon et al. J Am 
Coll Cardiol 2004). A study conducted by Todiere at al. showed as 
the extent of LGE ≥10% in patients with HCM is able to recognize 
additional patients at increased risk for malignant arrhythmic 
episodes in a population with low-to-intermediate ESC sudden 
cardiac death (SCD) risk score. For this reason, the same myocardial 
segmentation techniques used for the detection of myocardial infarct 
scars have been used, by some authors, for the quantification of 
myocardial fibrosis, especially in patients with HCM. However, there 
is no consensus regarding the technique of LGE quantification. 
Several CMR centers use different signal intensity thresholds as well 
as visual assessment for LGE analysis in patients with HCM. 
 
Myocardial segmentation techniques on late gadolinium 
enhancement sequence 
The area of hyper-enhancement in the LGE sequences, i.e. 
myocardial tissue damage, can be quantified in several ways. First, 
there is the manual method, which consists in manually marking the 
areas of altered signal considered pathological by the radiologist. 
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Manual contouring is considered the reference standard, but it can be 
time-consuming and may be subjective. 
In addition to the manual method, semi-automatic software has been 
developed that allows the quantification in grams and percentage of 
the LGE area. A common semi-automated method for detecting areas 
of LGE in the LV is the fixed-model approach, whereby intensities 
are thresholded to a fixed number of standard deviations (SD) from 
the mean intensity of nulled myocardium or blood pool. This model 
is known as the n -SD method, where n = 2 , 3 , 4 , 5 or 6. A second 
common fixed-model approach is the full-width-at-half-maximum 
(FWHM) approach, where half of the maximum intensity within a 
user-selected hyper-enhanced region is selected as the fixed intensity 
threshold. Using this threshold, a region-growing process is 
employed from user-selected seeds. These seeds are selected to be 
within infarcted regions such that they can be segmented with region-
growing. In both cases, user interaction is needed for each image to 
manually select suitable regions of interest (ROIs) used for 
calculating the threshold values (Karim et al. Med Image Anal 2016). 
Several studies report how the FWHM and 6-SD or 5-SD techniques 
are more reproducible, with no statistically significant differences in 
the quantification of the volume of LGE compared to the manual 
segmentation considered the reference standard. The 2-SD technique 
generates LGE volumes up to 2 times higher than the FWHM, 6-SD 
and manual techniques (Carminati et al. J Thorac Imaging 2016). 
However, there is no univocal consensus in the literature. Other 
authors showed that FWHM underestimates chronic MI size in those 
with MVO on the acute scan because of very high extracellular 
volume in the area previously occupied by MVO and should be 
avoided for assessing chronic MI size (Zhang et al. Clin Radiol 
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2020). While the 6-SD method appears the most promising and has 
been shown to have the highest accuracy to predict segment wall 
recovery in patients with chronic myocardial infarction and is similar 
to manual quantification in patients with both acute and chronic 
myocardial infarction. The 6-SD approach also performed well when 
using 2 different LGE sequences. Furthermore, the reproducibility of 
these techniques appears to be worse in HCM than in AMI or CMI 
(Mikami et al. J Cardiovasc Magn Reson 2014). 
As the aforementioned approaches require user input, making them 
prone to inter- and intra- observer variation, other approaches that are 
automatic have been developed. Hennemuth et al. (2008) modelled 
the intensities of homogeneous tissue in LGE CMR with a Rician 
distributions and an expectation- maximization (EM) algorithm was 
used for fitting the data. Pop et al. (2013) fitted Gaussian mixture 
models to myocardial tissue pixel intensities and correlated with 
histology. In Detsky et al. (2009), clustering in a feature space of 
steady-state and T ∗1 intensity values provided the segmentation 
which was shown to provide good correlation with FWHM. Tao et al. 
(2010) employed automatic thresholding using the Otsu method on 
bi-modal intensity histograms of myocardium and blood pool. The 
Otsu technique has been shown to accurately delineate MI size. But 2 
subsequent studies showed that Otsu overestimated MI size. More 
recently, the use of the graph-cut technique in image processing has 
been applied to segment infarct in several methods (Lu et al., 2012; 
Karim et al., 2014; Karimaghaloo et al., 2012). An advantage of this 
technique is that constraints can be placed on the resulting 
segmentation, allowing segmentation boundary regularization with 
region-based properties. It also predicts which pixels are statistically 
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most likely to be infarct based on prior probability distribution 
models.  
However, it should be noted that any semi-automated or automated 






In recent years, new advanced magnetic resonance (MR) techniques 
in cardiothoracic and abdominal imaging were developed adding a 
quantitative evaluation to the conventional qualitative image analysis. 
They are able to quantify MR signal intensity allowing for unbiased 
and reproducible assessments. Focusing on cardiac MR (CMR) 
imaging, there is a growing interest in new advanced techniques such 
as quantification of myocardial tissue damage and the emerging 
radiomics. 
On CMR imaging, late gadolinium enhancement (LGE) sequences 
are able to detect myocardial tissue damage 1–4. Moreover, the pattern 
of myocardial LGE may be helpful in the differential diagnosis of 
myocardial diseases, in particular in discriminating between ischemic 
and non-ischemic myocardial injuries 5–7. In myocardial infarction, 
the delayed myocardial enhancement in LGE sequences shows a 
characteristic subendocardial or transmural distribution 
corresponding to a particular coronary artery territory 2,8–10. In non-
ischemic conditions, such as cardiomyopathies, LGE does not 
correspond to any particular coronary artery territory and usually 
shows a subepicardial or mid-wall distribution, with sub-
endocardium sparing1,5,11–13. In patients with myocarditis, 
inflammatory lesions frequently show some LGE areas due to the 
enlargement of the extracellular volume 12,14–16. The typical LGE 
pattern in myocarditis is patchy with a prevalent 
subepicardial/midwall involvement, usually affecting the lateral free 
wall of the left ventricle18. However, sometimes, areas of LGE can 
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present a non-typical distribution so that the differential diagnosis of 
myocardial diseases can be a challenging in CMR imaging, usually 
requiring the knowledge of proper clinical setting19,20. In addition, 
CMR requires a high level of expertise and experience for a proper 
interpretation of cardiac diseases.  
Recently, there has been a growing interest in quantifying the extent 
of tissue damage seen on LGE-CMR for both ischemic and non-
ischemic pathologies, as this is considered to be an unfavorable 
prognostic factor15,21,22. The evaluation of scar tissue plays an 
important role in the prognosis and treatment of patients affected by 
ischemic injury, being an important predictor of left ventricular (LV) 
remodeling, cardiac dysfunction, and ventricular arrhythmias 23–25. In 
particular, the amount of post-myocardial infarction scar tissue and 
its transmural extension are considered to be predictors of mortality, 
and may be useful in selecting candidates for cardiac defibrillator 
implantation (ICD) 23,26. A quantitative evaluation of scar tissue 
extension is therefore essential, even if it is susceptible to 
reproducibility issues 27,28. Nowadays, most scar tissue quantification 
softwares are based on manual identification of a threshold value for 
CMR-LGE 5,6,23,28–30 and areas of hyperenhancement within the 
myocardium are identified without distinguishing between ischemic 
and non-ischemic alterations25,28,31-36.   
Radiomics is an emerging field of study in which the quantitative 
data “hidden” inside the standard medical images can be 
automatically extracted using a panel of sophisticated data 
characterization algorithms. These objective data, referred to as 
radiomic features, are often not visible to the human eye and can be 
used to make more accurate diagnoses, reducing interoperator error, 
and to predict clinical outcomes37. Currently, radiomics is most 
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commonly applied in oncologic imaging showing great results in 
cancer screening, diagnosis, and treatment evaluation38-41. However, 
there is a growing interest in using radiomics analysis in cardiac 
imaging. Texture analysis is the most common type of radiomic 
analysis performed in CMR imaging37. Some studies showed that 
texture analysis of unenhanced CMR images could be successfully 
used to identify, differentiate, and diagnose cardiomyopathies42,43. 
On this background, we chose to focus our study on advanced MR 
techniques in cardiac imaging because experience in this field is still 
limited, as opposed to abdominal imaging. In this setting, the aim of 
this study is to test two advanced CMR techniques: 
1) The custom made software FLORA (For Late gadOlinium 
enhanced aReas clAssification), developed by Medical Physics 
Department and Radiology Department AOUC to identify and 
classify LGE myocardial lesions automatically and to assess 
the transmural extent of ischemic lesions. 
2) The ability of texture features derived from CMR images in 
differentiating between myocardial infarction, myocarditis and 
healthy controls. 
Material and Methods 
	
 Study population 
By searching our Picture Archiving and Communication System 
(PACS), we retrospectively evaluated all 1243 patients who 
underwent a CMR examination between March 2018 and November 
2020. Of these, analysing LGE sequences, we selected only patients 
with one of the following inclusion criteria: a confirmed diagnosis of 
myocardial infarction with evident scar tissue on LGE sequences; a 
confirmed diagnosis of non-ischemic cardiomyopathy with evident 
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areas of LGE; no myocardial alterations on CMR, especially in LGE 
sequences. Exclusion criteria were: poor image quality, the presence 
of artefacts on LGE-CMR sequences, and incomplete CMR 
examination (due to claustrophobia or the absence of LGE 
sequences). The final cohort thus comprised 120 patients with the 
following characteristics (see Table 1): 40 had a confirmed diagnosis 
of myocardial infarction with evident scar tissue on LGE sequences; 
40 had a confirmed diagnosis of non-ischemic cardiomyopathy; 40 
did not show any myocardial alterations on CMR, especially in LGE 
sequences. The latter group was referred to CMR for the following 
clinical reasons: 30 patients with ventricular arrhythmias to identify a 
potential arrhythmogenic substrate (due to the presence of extra 
systoles on the ECG); 3 with a family history of sudden cardiac 
death; 2 with a family history of hypertrophic cardiomyopathy; 1 
with a left ventricle diverticulum detected at echocardiography; 2 
with a slightly increased right ventricle volume at echocardiography; 
and 2 with a slightly increased left ventricle volume at 
echocardiography. The final cohort of 120 patients was used to test 
the custom made software FLORA. Texture features analysis was 
performed on a subgroup of 60 patients, including 20 patients with 
myocardial infarction, 20 with myocarditis and 20 without any 
myocardial alterations on CMR (Table 2).  
This retrospective single-center study was conducted in accordance 
with the Declaration of Helsinki Ethical Principles and Good Clinical 
Practices and was approved by the Biomedical Research Ethics 
Committee of our institution. All patients gave their informed 
consent for the CMR examination with intravenous administration. 
Patients’ records were anonymized and de-identified prior to 
analysis. 
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Table 1: Final cohort of enrolled patients to test the custom made software 
FLORA. 
Group of patients Group details Number of 
patients 
Ischemic cardiomyopathy - 40 
Non-ischemic cardiomyopathy Hypertrophic cardiomyopathy 11 
Myocarditis 20 
Myopericarditis 2 
Becker's dystrophy 1 
Sarcoidosis 2 
Dilated cardiomyopathy 3 




No myocardial alterations on CMR - 40 
 
Table 2: Subgroup of patients in which texture analysis was performed. 
Group of patients Number of patients 
Myocardial infarction 20 
Myocarditis  20 
No myocardial alterations on CMR 20 
 
	 76	
 CMR protocol 
CMR examinations were performed using two different MR 
scanners. From the final cohort of 120 patients: 90 patients were 
scanned on a 1.5 T Magnetom Aera (Siemens Medical Solutions, 
Erlangen, Germany) (30 ischemic, 30 non-ischemic and 30 injury-
free); 30 patients were scanned on a 1.5 T Ingenia (Philips 
Healthcare, Best, The Netherlands)  (10 ischemic, 10 non-ischemic 
and 10 injury-free). From the subgroup of 60 patients: 30 patients (10 
myocardial infarction, 10 myocarditis and 10 without any alterations 
on CMR) were scanned on a 1.5 T Magnetom Aera (Siemens 
Medical Solutions, Erlangen, Germany); 30 patients (10 myocardial 
infarction, 10 myocarditis and 10 without any alterations on CMR) 
were scanned on a 1.5 T Ingenia (Philips Healthcare, Best, The 
Netherlands). 
Breath-hold retrospectively ECGgated cine steady state free 
processing images were acquired in the short-axis (SA) covered the 
entire LV (6 mm slices without gap).  
SA LGE-CMR images were acquired using breath-holds ECG-
triggered inversion recovery gradient echo sequences ten minutes 
after the administration of 0.1 mmol/kg Gadobutrolo (Gadovist, 
Bayer HealthCare), infused at 1ml/sec, followed by 20 ml saline with 
an automated injector. The inversion time was calculated for each 
patient by considering the null-point of the normal myocardium 
signal using a Look-locker sequence. Scan parameters for SA-LGE 
sequences on Siemens/Philips MR scanners were: 2D PSIR LGE, 
208x188 image matrix size, pixel size 1.63×1.63 mm2, slice thickness 
8 mm, no slice gap, echo time 1.12 ms, flip angle 40° and 3D PSIR 
LGE, 256×256 image matrix size, pixel size 1.17×1.17 mm2, slice 
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thickness 8 mm, no slice gap, echo time 2.2 ms, flip angle 20° 
respectively (Table 3). 
On the 1.5 T Siemens Magnetom Aera scanner, for T1 mapping, we 
used ECG-triggered acquisitions modified by Look-Locker inversion 
recovery (MOLLI), using the scheme 3(3)3(3)5; postcontrast 
MOLLIs were performed 15–20 min after the gadolinium bolus, 
using the scheme 4(1)3(1)2.  
On the 1.5 T Philips Ingenia scanner, for T1 mapping, we used ECG-
triggered acquisitions Shortened MOdified Look-Locker Inversion 
recovery (ShMOLLI), using the scheme 5(1)1(1)1. 
CMR data were analysed using a dedicated workstation (IntelSpace, 



















Table 3: Scan parameter of a cardiac magnetic resonance (CMR) protocol 
Parameter SA cine SA LGE PSIR T1 mapping native 

















300 340 300 360 300 
TR (ms) 3.1 3.1 713 4.3 311.46 1.97 
TE (ms) 1.3 1.53 1.12 2.1 1.12 0.88 
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PSIR phase sensitive inversion recovery, LGE late gadolinium enhancement, TR 





 FLORA software workflow 
FLORA is an automatic tool designed to identify myocardial 
alterations and distinguish ischemic from non-ischemic LV lesions 
on CMR-LGE images in the short axis. The software also evaluates 
transmural extension in the case of ischemic lesions. The software is 
written in Matlab (2019, version 7.10.0, R2019a, Natick, 
Massachusetts: The MathWorks Inc). A schematic description of its 
workflow is provided in Figure (1). 
For each patient, a radiologist with seven years of experience in 
CMR selected a single slice in the SA-LGE sequence in which the 
myocardial alteration was present/visible (Figure 1a). The 
myocardium was then segmented by delineatiing both the epicardial 
and endocardial borders with two regions of interest (ROIs): ROIext, 
corresponding to the epicardial border; and ROIint, corresponding to 
the endocardial border (Figure 1b). Papillary muscles were excluded 
from the segmentation. This was the only manual operation required 
while all the remaining operations described further on were fully 
automatic, and thus completely independent from the operator. 
Following slice segmentation, a mask is automatically created and 
applied to the SA-LGE image to select the pixels located between 
ROIext and ROIint corresponding to the myocardium region. Signal 
intensity profiles, defined in a radial direction, are then extracted 
using the standard Matlab ‘improfile’ function, starting from the 
centroid of ROIint and extending to ROIext (Figure 1c-d). Using the 
mask image, all of the profiles’ pixel values inside ROIint are set to 
zero. The histogram of myocardial signal intensities on the LGE 
image, which is the starting point for the automatic threshold 
calculation (Figure 1e), is then calculated, dividing the intensity 
range into 20 bins. The threshold value distinguishes the pixels 
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belonging to the areas of enhanced signal (i.e. over the threshold) 
from those of the injury-free myocardium. It is calculated using two 
different methods: the ‘double-gaussian fit’ method and the ‘fixed-
shift’ method. It is noteworthy that the automatic threshold estimate 
must be sensitive enough to detect slight gadolinium enhancement, 
and robust enough to not be affected by intensity fluctuations due to 
local variations in the signal-to-noise ratio. A detailed description of 
the two methods is given in the Supplementary Materials. 
Pixels in profiles with an intensity higher than the estimated 
threshold value, and with at least three other neighboring pixels over 
the threshold, are identified as pathological. The neighbor check is 
carried out in the masked image via a 3x3 matrix centered on every 
pixel to exclude local signal intensity fluctuations. Neighboring 
pixels over the threshold are also included in the identified 
pathological region (Figure 1f). 
The software code then checks whether the pixel clusters identified 
as pathological belong in part to ROIint (i.e. if they are partially in 
contact with the endocardial border). If this occurs with an extension 
of the overlap of at least 5 mm, the whole cluster is classified as 
ischemic (red colormap). Otherwise, if there is no overlap, it is 
classified as non-ischemic (yellow colormap). We also added the 
orange colormap for non-ischemic lesions reaching the endocardium 
with an overlap extension < 5mm. 
Examples of these classifications are given in Figure 1g. 
The software provides both 2D and 3D visualization methods for the 
classification map. The 2D method consists of the SA-LGE-CMR 
sliced with the red, yellow and orange colormap superimposed on the 
detected pathological areas. The 3D method includes a color bar chart 
with a bar height equal to the pixel intensity. Blue is assigned to 
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blood pixels; green to injury-free myocardium pixels; red to ischemic 
lesion pixels; and yellow and orange to non-ischemic pixels (Figure 
1g). 
Finally, a quantitative estimate of the maximum transmurality for 
each ischemic area is provided, with values ranging from 0 (no 
ischemic pattern) to 1 (totally transmural extent of the lesion).  
 
Fig. 1 Step-by-step representation of the FLORA workflow: the orange-dashed 
line shows the required manual operations, the purple-dashed line the automatic 
operations. 
 
FLORA Software Validation 
FLORA’s performance was compared with the radiologist’s 
evaluation for the entire 120-patient sample (40 with ischemic lesion, 
40 with non-ischemic lesion, and 40 with injury-free myocardium). 
The following tasks relating to the methods for automatically 
selecting the threshold were used in the comparison: 
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1. Lesion identification. 
2. Lesion classification: ischemic, non-ischemic, injury-free, mixed 
pattern (both ischemic and non-ischemic pixel). 
3. Assessment of the extent of the identified lesion: concordant, 
overestimated or underestimated assessment. The assessment was 
considered overestimated when the extent of the myocardial scar, as 
indicated by the software, involved more myocardial segments than 
the radiologist’s visual evaluation, when the percentage of 
transmurality was higher (in the case of ischemic lesion), or when the 
presence of artifacts or noise was classified as myocardial damage. It 
was considered understimated when the extent of the myocardial scar 
involved fewer myocardial segments than the visual evaluation, when 
the percentage of transmurality was lower, or when small areas of 
LGE were not recognized. 
4. Inter-reader agreement in transmurality evaluation. The 
distribution of ischemic lesions and the transmurality of fibrosis was 
evaluated by the radiologist according to the American Heart 
Association’s 17-segment model 44. The extension of myocardium 
scar in each segment of the selected silce was scored according to 
four categories defined by the percentage thickness of affected 
myocardium: 1=1–25%; 2=26–50%; 3=51–75%; 4=76–100%. A 
total of 52 segments were evaluated. Afterwards, three radiologists, 
two with four years and one with 20 of experience in CMR, were 
asked to perform a blinded estimation of the transmurality extension, 
with and without the software, in a reduced subgroup of 20 patients 
with ischemic lesions involving <75 % of myocardial thickness. This 
was done to asses whether the software could increase the inter-
reader agreement in the evaluation of transmurality when LGE 
images revealed an incomplete transmurality pattern.  
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Texture analysis 
The radiomics workflow included (a) lesion segmentation, (b) 
features extraction, and (c) features selection (Figure 2). 
Image segmentation: SA-CINE, SA-LGE and T1 mapping native 
images were retrieved from our PACS and loaded into the 3D Slicer 
software, version 4.10.2 (open source software; 
https://www.slicer.org/) for segmentation. For each patient, a 
radiologist with seven years of experience in CMR selected a single 
slice of the SA-LGE sequence in which the myocardial alteration was 
visible. The correspondent same slice was selected on the SA-CINE 
sequence choosing the end-diastolic phase  and on the native T1 
mapping sequence. The areas to be analyzed were defined by 
contouring a ROI . The whole myocardium was segmented on the 
previously selected SA-LGE, SA-CINE and native T1 mapping 
images by delineating the endocardial and epicardial borders of the 
LV. In those patients with myocardial infarction and myocarditis, 
another ROI was drawn on the SA-LGE slice encircling the visible 
area of fibrosis; the healthy myocardium region was then derived by 
subtracting the lesion segmentation from the whole myocardium 
segmentation. Texture analysis was then performed: 1) on the whole 
myocardium; 2) on the healthy myocardium; 3) on the myocardium 
with fibrosis.  
Texture feature extraction: A total of  93 quantitative features were 
extracted from the segmented ROIs, including first-order features 
(providing a global summary of the signal intensities within the 
segmented volume) such as mean, median, variance, skewness, 
kurtosis (pointiness), and entropy (randomness or disorder) and 
second-order features (quantities describing the relationship of 
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neighbouring voxel signal intensities) calculated from derived 
matrices such as grey-level co-occurrence matrix (GLCM) and grey-
level run-length matrix (GLRLM). 
Texture feature selection: Kruscal-Wallis test, with Dunn’s test post-
hoc analysis, was performed on the segmented ROIs to identify the 
most significant features in distinguishing between myocardial 
ischemia, myocarditis and absence of alterations on CMR. In order to 
reduce data overfitting, a dimensionality reduction was performed on 
the features obtained from each statistical test. The most significant 




Fig. 2 Schematic shows radiomics workflow in CMR on late gadolinium 
enhancement images. First, routine medical-grade images are acquired and 
reconstructed. Second, images are manually segmented to define ROIs. The 
whole Myocardium is segmented by delineating the endocardial and epicardial 
borders of the LV. The region of abnormal myocardium is segmented by 
encircling the visible area of fibrosis and the healthy myocardium region is 
derived by subtraction. Third, quantitative radiomics features are extracted from 
ROIs to build a large set of data. Finally, extracted data are statistically 
analyzed.	
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 Statistical analysis 
Software-radiologist concordance for Tasks 1 (identification) and 2 
(classification) was assessed by means of contingency tables and 
Cohen's Kappa with SPSS software (IBM SPSS Statistics v.27.0, 
Armonk, NY, IBM Corp.).  The analysis was repeated with results 
grouped by MR scanner, taking both of the threshold estimating 
methods into account. The percentage of lesion extent that was 
correctly estimated, overestimated and underestimated by FLORA 
was calculated for Task 3. Inter-reader agreement in transmurality 
evaluation (Task 4), both with and without the use of the software, 
was assessed using Fleiss Kappa. 
Statistical analisys on the features extracted from the SA-LGE, SA-
CINE and native T1 mapping segmented images was performed with 
SPSS software with non-parametric tests, separating patients 
according to the MR scanner (Siemens and Philips). 
Kruscal-Wallis test, with Dunn’s test post-hoc analysis, was 
performed on the segmentations of the whole myocardium to obtain 
the most significant features in distinguishing between myocardial 
ischemia, myocarditis and absence of alterations on CMR.  
Same analysis was performed on the abnormal myocardium and 
healthy myocardium regions segmented on the SA-LGE images.  
In order to decrease data overfitting, a dimensionality reduction was 
performed on the significant features obtained from each statistical 
test using principal component analisys and the Perason’s correlation 








The analysis inclulded 120 patients aged between 18 to 84 years, 
mean age 52 ± 34; 91men and 39 women.  
Examples of ischemic and non-ischemic lesion classification, with 
the corresponding 3D visualization, are given in Figure 3. 
 
 
Fig. 3 Images a-d: A 76-year-old male patient with a previous episode of 
myocardial infarction. LGE- SA reveals an area of sub-endocardial 
enhancement in the anterior wall of the mid-cavity (a). The alteration is correctly 
identified and classified on the 2D image provided by FLORA (ischemic area in 
red) (b,c), while the 3D image (d) help to assess the degree of involvement of the 
affected wall. 
Images e-h: A 65-year-old female with hypertrophic cardiomyopathy involving 
the interventricular septum. In LGE, the short axis reveals an area of 
enhancement at the level of the septum, particularly at the anterior and posterior 
right ventricle insertion points (e). The tissue damage is correctly identified and 




Table 4 gives a comparative indication of the software’s performance 
in identifying lesions for the two methods of automatic threshold 
estimation (Task 1). Clearly, there were a very low number of false 
negatives. Cohen’s Kappa results for the whole dataset and grouping 
data by MR scanner were as follows: (double-gaussian fit’ method / 
fixed-shift method): 0.621/0.554 (whole dataset); 0.668/0.549 
(Siemens scanner); 0.471/0.571 (Philips scanner). For the Altman 
classification, the agreement ranged from moderate to substantial. 
The performance of the double-gaussian fit method, meanwhile, was 
comparable to that of the fixed-shift method. 
These results are due to the relatively high number of false 
positives. Of the 40 patients classified by the radiologist as injury-
free on the LGE sequences, 18/20 (double-gaussian fit method / 
fixed-shift method) were considered positive by the software due to a 
low number of pixels, indicating an altered myocardial signal that 
does not affect the radiological evaluation (evidence of confounding 
noise). On the other hand, FLORA identified both ischemic and non-
ischemic myocardial lesions in almost all cases (80/80 and 79/80 for 
the double-gaussian fit method and fixed-shift method, respectively, 










Table 4: contingency table for lesion identification using the two methods for 
automatic threshold estimation (Task 1). 












Negative 22 20 18 20 
Positive 0 1 80 79 
 
 
Table 5 shows the contingency table comparing the software’s 
performance for lesions classified acording to the two methods of 
automatic threshold estimation (Task 2). The classification works 
very well for lesions classified as ischemic by the radiologist (Group 
1 in Table 5). However, it works less well for cases that do not 
present signal alterations (Group 3 in Table 5). FLORA correctly 
classified ischemic lesions (Group 1 in Table 5) in most cases (34/40 
with the double-gaussian fit method and 38/40 with the fixed-shift 
method). The remaining cases (6 and 2, respectively) were classified 
as a mixed pattern for the presence of ischemic and non-ischemic 
pixels. Non-ischemic lesions (Group 2 in Table 5) were correctly 
classified in 28/40 cases using the double-gaussian fit method and 
32/40 cases using the fixed-shift method. For the fixed-shift method, 
the software failed to recognise a subtle mesocardial LGE in a patient 
with dilated cardiomyopathy in one instance, while the remaining 
cases were classified as mixed pattern. 
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Cohen’s Kappa was used to assess the software’s performance in 
lesion classification. The results for the whole dataset grouped by 
MR scanner were as follows (double-gaussian fit method / fixed-shift 
method): 0.595/0.662 (whole dataset); 0.594/0.669 (Siemens 
scanner); 0.597/0.642 (Philips scanner). As for the identification task, 
the agreement ranged from moderate to substantial with higher 
Cohen’s Kappa values, while the fixed-shift method performed better 
compared to the double-gaussian fit method. 
 
Table 5: Contingency table for lesion classification for the two automatic 
threshold estimation methods (Task 2). 
  1           2                   3   4 


















1 34 38 0 0 0 0 6 2 
2 0 0 28 32 0 1 2   7 
3 3 4 3 2 22 20 12 14 
4 0 0 0 0 0 0 0 0 
1: ischemic lesion, 2: non ischemic lesion, 3: injury-free, 4: mixed-pattern.  
DGF, Double-gaussian fit method, FS Fixed-shift method 
 
Table 6 gives the percentage of overestimated, underestimated and 
correctly evaluated lesion extent for the whole dataset grouped by 
MR scanner (Task 3). An example of the extent evaluation is given in 
Figure 4. 
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Fig. 4 Images a-c: 57-year-old male with  ischemic myocardial damage. LGE-
SA reveals an ischemic scar of the inferior and infero-lateral wall of the left 
ventricle (a). Using the double-gaussian fit method, FLORA overestimates the 
ischemic lesion in the 2D image, marking altered pixels in segments not 
identified by the radiologist (black circles) (b). These are correctly identified 
with the fixed-shift method (c). 
Images d-f: 25-year-old male with hypertrophic cardiomyopathy involving the 
interventricular septum. LGE-SA reveals diffuse enhancement of the 
interventricular septum (d). FLORA underestimates myocardial fibrosis more 
frequently with the double-gaussian fit method (e) than with the fixed-shift 
method (f). 
 
There was good agreement between the FLORA software and the 
radiologist for the evaluation of the extent of the lesion (Cohen’s 





Table 6: Percentage of correctly evaluated lesion extent (Task 3). 











67% 76% 77% 70% 
Overestimated 23% 12% 17% 13% 
Underestimated 10% 11% 6% 17% 
 
Table 7 gives the Fleiss’s Kappa values used to assess the inter-
reader agreement in transmurality estimation (Task 4) for patients 
with transmurality extent < 75% after visual evaluation. The 
agreement levels increased significantly when radiologists were 
assisted by the software, increasing from slight to 
moderate/substantial.  
 
Table 7: Fleiss’s Kappa to assess inter-reader agreement in evaluating scar tissue 










1 0.100 0.484 0.484 
2 0.130 0.643 0.481 
3 0.190 0.744 0.553 
4 - 1.000 - 
Transmurality grade (percentage of affected myocardial). 1:1–25%, 2: 26–50%, 





The total amount of significant features derived from each of the 
selected images on both the MR scanners and the features selected 
after the dimensionality reduction with the correspondig p-value (p) 
are reported below. When a three group comparison was made, the 
two groups that passed the Dunn’s test are also reported. 
- On the SA-LGE images the significant features extracted were:  
a. From the analysis of the  the whole myocardium 
comparing the three groups (myocardial ischemia (I), 
myocarditis (M) and no alterations on CMR (S)): for the 
Ingenia scanner a total of 59 features, 5 after 
dimensional reduction: Contrast (GLCM) (p = 0.001; I-
S, I-M), Correlation (p < 0.001; I-S) Skewness (p = 
0.015; I-S), Maximum (p < 0.001; I-S, I-M), 
JointEnergy (p = 0.011; I-S, I-M); for the Aera scanner a 
total of 62 features, 7 after dimensional reduction: 
Contrast (GLCM) (p = 0.005; I-S, M-S), Imc1 (p < 
0.001; I-S), Skewness (p = 0.005; I-S, M-S), 
RobustMeanAbsoluteDeviation (p < 0.001; I-S, M-S), 
RootMeanSquared (p < 0.001; I-S, M-S), Entropy (p < 
0.001; I-S, M-S), Mean (p < 0.001; I-S, I-M); the 
significant features for both scanners after dimensional 
reduction were Contrast (GLCM) and Skewness (Table 
8; Figure 5). 
b. From the analysis of the healthy myocardium comparing 
the three groups (myocardial ischemia (I), myocarditis 
(M) and no alterations on CMR (S)): for the Ingenia 
scanner a total of 13 features, 2 after dimensional 
reduction: Skewness (p = 0.020; I-S), Stregth (p = 0.002; 
	 94	
I-S, I-M); for the Aera scanner a total of 45 features, 6 
after dimensional reduction: GrayLevelVariance 
(GLDM) (p = 0.002; I-S, M-S), 
RobustMeanAbsoluteDeviation (p = 0.010; I-S), Mean 
(p = 0.018; I-S), SizeZoneNonUniformity (p = 0.032; I-
S), LargeAreaHighGrayLevelEmphasis (p = 0.037; I-S), 
Coarseness (p = 0.010; I-S); no significant feature for 
both scanners after dimensional reduction was found. 
c. From the analysis of the myocardium with fibrosis 
comparing myocardial ischemia and myocarditis: for the 
Ingenia scanner a total of 59 features, 5 after 
dimensional reduction: MCC (p < 0.001), 
ClusterProminence (p < 0.001), MeanAbsoluteDeviation 
(p < 0.001), Minimum (p = 0.019), 
SmallAreaLowGrayLevelEmphasis (p = 0.009); for the 
Aera scanner a total of 59 features, 4 after dimensional 
reduction: HighGrayLevelEmphasis (p = 0.029), Idmn 
(p= 0.024), RobustMeanAbsoluteDeviation (p = 0.013), 
10Percentile (p < 0.001); no significant feature for both 
scanners after dimensional reduction was found. 
- On the SA-CINE images the significant features extracted 
were: 
a) From the analysis of the whole myocardium comparing 
the three groups (myocardial ischemia (I), myocarditis 
(M) and no alterations on CMR (S)): for the Ingenia 
scanner a total of 2 features, 1 after dimensional 
reduction: MCC (Maximal Correlation Coefficient) (p= 
0.013; I-S); for the Aera scanner a total of 19 features, 5 
after dimensiona reduction: GrayLevelNonUniformity 
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(GLDM) (p= 0.002; I-S, I-M), DependenceVariance 
(p=0.001; I-M), ClusterShade (p= 0.013; I-S), 
LargeAreaHighGrayLevelEmphasis (p= 0.0013; I-S), 
Coarseness (p= 0.012; I-M); no feature significant for 
both scanners after dimensional reduction was found. 
- On native T1 mapping images the significant features extracted 
were: 
a) From the analysis of the whole myocardium comparing 
the three groups (myocardial ischemia (I), myocarditis 
(M) and no alterations on CMR (S)): for the Ingenia 
scanner a total of 16 features, 3 after dimensional 
reduction: ShortRunHighGrayLevelEmphasis (p = 
0.008; I-M), ClusterShade (p = 0.032; I-M), 
RobustMeanAbsoluteDeviation (p = 0.010; I-S); for the 
Aera scanner a total of 52 features, 5 after dimensiona 
reduction: ClusterShade (p = 0.006; I-S), 
MeanAbsoluteDeviation (p = 0.002; I-S), Variance (p < 
0.001; I-S, M-S), GrayLevelNonUniformity (GLSZM) 
(p = 0.017; I-S), LargeAreaLowGrayLevelEmphasis (p 
= 0.023; I-S); the feature significant for both scanners 













Table 8 : List of significant quantitative texture features for the Kruskal-Wallis 
test between the three pathology groups for both MR scanners after 
dimensionality reduction. For each feature the p-value, the median and the 
Tukey’s first and third quartile values are reported separately for the two MR 
scanners and for each pathology group. Pathology groups: 1 = myocardial 




Median 1st / 3rd Quartile Brief feature 




(GLCM) 0.001 0.005 
1 33.6 14.3 27.0 / 49.1  
7.7 /  
16.4 
First-order 




variation. It is 






2 13.1 10.6 8.9 / 19.5 7.8 /  22.6 
3 13.0 5.0 10.0 / 14.2 
4.2 /  
5.8 
SA-LGE 
3 groups Skewness 0.015 0.005 

















2 0.89 0.76 0.76 / 1.03 
0.55 / 
1.02 
3 0.21 0.10 -0.09 / 0.63 
0.03 / 
0.32 
T1          3 
groups ClusterShade 0.032 0.006 
1 -665 206 -952 /  -97 
81 /  
321 
Second-order 












2 28 85 -231 / 66 34 /  124 
3 -213 8.0 -1442 / 41 





Fig. 5 Contrast (GLCM), Skewness and ClusterShade boxplots for the three 
groups of pathology and the two different MR scanners: a) for Philps Ingenia 1.5 




The FLORA tool was designed for the identification, classification 
and evaluation of the extent and degree of transmurality (for ischemic 
lesions only) using LGE – a validated method for assessing 
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myocardial damage and a prognostic marker in patients with 
myocardial ischemia45,46. The ‘areas of “irreversible” damage 
appearing as transmural bright alterations on LGE images should be 
correctly classified, and a distinction between ischemic and non-
ischemic lesions should be done. Many existing studies focus on 
developing new types of LGE sequences 10,47. In recent years, dark-
blood LGE sequences have been proposed. In these sequences the 
scar-blood contrast is increased, thus improving the visibility of 
subendocardial scars 6. However, these images are usually still 
analyzed by a visual assessment. Furthermore, if large areas of 
transmural LGE are identified, it is more difficult to determine the 
degree of transmurality or to differentiate the ischemic areas from 
other not ischemic lesions that show extended LGE. Moreover, 
currently available software solutions allow for scar tissue 
quantification by manually setting a LGE threshold. These are of 
limited use in clinical practice and don’t help radiologists in 
classifying the areas of LGE. 
FLORA showed moderate to good agreement with the radiologist in 
the identification and classification of myocardial signal changes in 
LGE sequences. The best and perhaps most promising result from the 
study is that FLORA produced hardly any false negatives (i.e. it 
showed very high sensitivity), which is an important feature for this 
type of software.  
The best results were obtained in the classification of ischemic 
myocardial damage, which was correctly identified in 85% and 95% 
of cases for the double-gaussian fit method and the fixed-shift 
method, respectively. In the remaining cases it was classified as a 
mixed-pattern due to the presence of some occasional yellow pixels 
(classified as non-ischemic) resulting from small artifacts on the 
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LGE-SA images. In one case, the identification of yellow pixels in 
the middle of the ischemic area was due to the presence of no-reflow 
areas in the segmentation. Despite this, the extent of the ischemic 
myocardial scar was correctly recognized in these cases. In just two 
cases, both related to the use of the double-gaussian fit method to 
determine the threshold, the image indicated the presence of further 
areas of miocardial alteration, in addition to the ischemic area. 
FLORA thus displayed low specificity, mainly due to the incorrect 
classification of few isolated pixels that did not affect the 
radiologist’s final diagnosis. 
FLORA was able to provide an automatic quantitative evaluation of 
the extent of trasmurality of an ischemic lesion, which may be of 
assistance to radiologists. We have shown that there is a low 
agreement among radiologists in defining the degree of transmurality 
of an ischemic lesion when the myocardial damage affects less than 
75% of the myocardial thickness. In these cases, visual estimation of 
the extent of transmurality was more difficult and thus less 
reproducible. Agreement among readers in the quantitative 
evaluation of the extent of transmurality of ischemic lesions 
increased from slight to moderate/substantial with the assistance of 
FLORA, indicating that the software can reduce inter-reader 
variability in scar-tissue quantitative evaluation using LGE for 
patients with ischemic lesions. This last aspect is crucial, given the 
importance of a reliable quantitative evaluation of the degree of 
transmurality of the ischemic lesion, both for patient's prognosis and 
for defining the correct course of treatment48,49 . 
Non-ischemic changes were also correctly recognized in most cases. 
However, some of them were classified as mixed pattern (30% and 
17.5% of cases for the double-gaussian fit method and fixed-shift 
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method, respectively). This is because non-ischemic alterations 
typically have a non-sub-endocardial enhancement pattern, often 
located in the mid-wall or epicardial regions 5,50. The sub-
endocardium can also be involved, especially when the myocardial 
damage is very extensive, but it does not follow any coronary 
distribution, and involvement is patchy and of limited extension. 
There is thus more difference in the software’s representation of the 
tissue damage in the non-ischemic group, compared with the 
ischemic group.  
Furthermore, the results did not depend significantly on the MR 
scanner used, suggesting that the results obtained for the validation 
dataset may also be confirmed in other CMR examinations. 
Multicenter validations on larger populations are certainly necessary. 
The software was also able to increase the detection of sub-
endocardial sparing areas, allowing for a better classification between 
ischemic and non-ischemic lesions (Figure 6). Extensive alterations 
featuring significant edema, as it happens for example in myocarditis 




Fig. 6 60-year-old male suffering from myocarditis with an area of enhancement 
in the interventricular septum at the base of the LV on LGE-SA (black arrow) 
(a). FLORA increases the detection of sub-endocardial sparing areas and 
correctly classifies myocardial damage as non-ischemic (b) vs ischemic (c). 
 
FLORA’s worst performance was in occasional incorrect 
classification of injury-free myocardial areas (medium specificity). 
This depends on the fact that a very high sensitivity was preferred, 
even at the expense of observing some false positives. 
In our study population only one false negative was observed: it was 
a patient suffering from dilated cardiomyopathy, who had very thin 
walls with low intramyocardial enhancement in the septum. This is 





Another limitation is that FLORA can confuse some motion artifact 
patterns with areas of altered LGE signal (Figure 7). However, this 
does not significantly affect the use of the software, as images with 
artifacts are easily identified by the radiologist. This misclassification 
can thus be easily identified. Furthermore, even if an automatic 
threshold recognition method is used, the radiologist’s intervention 
for myocardium segmentation is always required. This leads to a 
minimal interobserver variability, however lower than that observed 
in visual evaluation. Finally, another important limitation of this 
study is that the FLORA software results were compared only with 
the standard radiologist’s evaluation. In future, it could be very 
interesting compared FLORA performance with a semiquantitative 
software analysis of LGE areas currently available. 
Nevertheless, the FLORA software results have an important clinical 
significance. In particular, FLORA can reduce inter-reader variability 
in the radiologist’s final diagnosis especially if there are LGE areas 
with non-characteristic distribution and/or the radiologist have a low 
level of expertise and experience. Moreover, FLORA could be an 






Fig. 7 Small artifacts on the LGE SA sequence (white arrowhead) in a patient 
classified as injury-free by the radiologist (a) are recognized by FLORA as areas 
of non-ischemic altered signal (black circles) (b). 
 
FLORA’s future developments will focus on radiomics techniques 
being integrated into the classification kernel of the software. For this 
reason, we started to evaluate the diagnostic value of texture features 
analysis in differentiating between myocardial infarction, myocarditis 
and healthy controls. To our knowledge, there are only few studies 
concerning the diagnostic value of texture analysis based on CMR 
images. The main finding of our study was the identification of three 
features significant for both MR scanners after dimensional 
reduction. Specifically, from the analysis of the whole myocardium 
on the SA-LGE images, we identified Contrast (GLCM) and 
Skewness as texture features significant for both scanners after 
dimensional reduction while, from the analysis of the whole 
myocardium on native T1 mapping images, ClusterShad was 
identified as a significant feature for both MR scanners.  
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In particular, on the SA-LGE images, for both scanner employed, a 
statistically significant difference in Contrast (GLCM) was observed 
between myocardial infarction and healthy controls (p <0.05) so that 
myocardial infarction showed more irregular intensity patterns 
compared to patients with no alterations on CMR. Moreover, in 
patients with no alterations on CMR, Skewness was close to 0 (the 
values were symmetrically distributed) while in myocardial infarction 
and in myocarditis it was close to 1 (the values were asymmetrically 
distributed, with a distribution that presents a tail at the higher pixel 
values, corresponding to those relating to the myocardial scar).  
In addition, from the analysis of the whole myocardium on SA-LGE 
images, myocardial infarction showed more irregular intensity 
patterns (Contrast GLCM), higher maximum value of signal intensity 
(Maximum), and a less homogeneous pattern (Joint Energy) for the 
Philips Ingenia scanner and a higher mean value of signal intensity 
(Mean) for the Siemens Aera scanner compared to myocarditis. We 
found a greater difference between myocardial infarction and healthy 
control compared to myocarditis, with 5 texture parameters resulting 
statistically different for the Philps Ingenia scanner (Contrast GLCM, 
Correlation, Skewness, Maximum, Joint Energy: all p<0.05), and 7 
for the Siemens Aera scanner (Contrast GLCM, Skewness, Imc1, 
Root Mean Squared, RobustMeanAbsoluteDeviation, Entropy and 
Mean: all p<0.05). Entropy was higher in both the myocardial 
infarction and myocarditis groups compared to group with no 
alterations on CMR, because it reflects how irregular or “random” the 
pixel intensity distribution is. In addition, myocarditis and 
myocardial infarction showed a greater magnitude of the intensity 
values (RootMeanSquared) and a higher value of 
RobustMeanAbsoluteDeviation than healthy controls. 
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RobustMeanAbsoluteDeviation is a first-order feature and it is the 
mean distance of all intensity values from the Mean Value calculated 
on the subset of image array with gray levels in between, or equal to 
the 10th and 90th percentile. Therefore, texture analysis was shown to 
be a promising tool in discriminating between these myocardial 
diseases with the largest number of texture parameters with a 
statistically significant difference identified on the SA-LGE images. 
This is an important result because radiomics presents a novel 
quantitative image analysis technique with potential to improve the 
diagnostic accuracy and confidence of CMR, especially when 
radiologists with low level of expertise and experience evaluate 
images. In this setting, texture analysis could be uses as a tool for 
self-training programs. 
From the texture analysis of native T1 maps, we identified 
ClusterShade as a texture feature significant for both scanners 
obtained after dimensional reduction. ClusterShade is a second-order 
feature and  it is a measure of the uniformity of the image; a higher 
cluster shade implies greater asymmetry about the mean. However, 
for the Ingenia scanner, myocarditis showed a higher value of 
ClusterShade than myocardial infarction while, for the Aera scanner, 
myocardial infarction showed a higher value of ClusterShade than 
patients without alterations on CMR (Figure 5). This difference 
between the two scanner employed could be explained by the limited 
number of study subjects, as it is shown in the blox plots by the high 
degree of dispersion in the data, or by a higher variability due to 
different parameters of acquisition. Major sources of variability for 
radiomics features are MR scanners, image acquisition and 
reconstruction parameters, and ROI delineation. Many image 
acquisition–related factors, including spatial resolution, signal-to-
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noise ratio, MR field strength and image slice thickness, are a 
potential source of confounding elements in texture analysis. 
However, little to no study has been done to discern how these 
factors specifically affect cardiac MRI radiomics51,52. Beyond 
ClusterShade, we identified other significant features after 
dimensional reduction for the Ingenia scanner 
(ShortRunHighGrayLevelEmphasis, p = 0.008; 
RobustMeanAbsoluteDeviation, p = 0.010) and for the Aera scanner 
(MeanAbsoluteDeviation, p = 0.002; Variance, p < 0.001; 
GrayLevelNonUniformity GLSZM, p = 0.017;  
LargeAreaLowGrayLevelEmphasis, p = 0.023). Therefore, 
standardized acquisition and reconstruction protocol will be needed 
to reduce the limits of bias and variance and to create the most robust 
models. 
In our study, no texture features derived from the SA-CINE images 
with a statistically significant difference for both scanners after 
dimensional reduction was found. This result is not in accordance 
with other studies that demonstrate the ability of CMR texture 
analysis based on non-contrast cine images to differentiate between 
myocardial diseases and healthy myocardium. Baessler et al, in two 
different studies, showed significant differences between patients 
with hypertrophic cardiomyopathy and healthy controls and between 
individuals with myocardial infarction and healthy controls through 
texture analysis of non-contrast cine images53,54.  In addition, Larroza 
et al. demostrated the ability of texture analysis of non-contrast cine 
images to accurately identify the non-viable myocardium in patients 
with myocardial infarction with 92% sensitivity and AUC of 0.84955. 
Schofield et al., in their study on 216 patients, found that texture 
analysis of unenhanced short axis cine images shows promise in 
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discriminating between the aetiologies of left ventricular 
hypertrophy42. Actually, considering each MR scanner separately, we 
found some statistically significant features after dimensional 
reduction: on the Ingenia SA-CINE images, MCC was  statistically 
different between myocardial infarction and patients without 
alterations on CMR (p=0.013); on the Aera SA-CINE images, 
GreyLevelNonUniformity GLDM (Gray Level Dependence Matrix ), 
DependenceVariance, and Coarseness were  statistically different 
between myocardial infarction and myocarditis, while 
GreyLevelNonUniformity GLDM, ClusterShade and 
LargeAreaHighGrayLevelEmphasis were  statistically different 
between myocardial infarction and healthy controls. However, none 
of these features were common to both MR scanners and this finding 
is very important because differences in radiomics features reflect 
variations in image acquisition and processing, and not only in tissue 
characteristics. As we pointed out above, one of the most important 
challenges for radiomics is the reproducibility of the features so there 
is a urgent need to identify radiomics features that are robust to real-
life variations in CMR images56. In their review on Radiomics, 
Gillies et al. highlighted that a restrospective radiomics investigation 
must be validated against a completely independent data set, 
preferably from another institution41. 
Beyond the integration between FLORA and radiomics, another 
future development of our work could be to evaluate the prognostic 
value of texture features especially in patients with myocardial 
infarction. Indeed, a study has shown correlation of texture features 
to arrhythmia risk in post-myocardial infarction patients57. A recent 
study of Cheng et al. evaluated the prognostic value of texture 
features based on LGE-CMR images in 67 hypertrophic 
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cardiomyopathy patients with systolic dysfunction. They found that 
some texture features linked to LGE heterogeneity are strongly 
associated with adverse events in their study population58. Finally, 
from the integration between FLORA and radiomics we could 
developed an automated machine learning algorithm for LGE 
quantification in hypertrophic cardiomyopathy help in risk 
stratification. Recently, Augusto et al. have been developed an 
automated machine learning method of measuring left ventricular 
maximum wall thickness in hypertrophic cardiomyopathy that have 
shown to be superior to human experts with potential implications for 
a more accurate diagnosis and risk stratification59. 
The main limitation of this preliminary study on radiomics is being a 
retrospective single-centre study with a limited number of subjects 
because the most rigorous radiomics investigation requires a 
prospective multicenter trial with standardized acquisition and 
reconstruction protocols. In addition, multiple texture parameters are 
challenging to rationalise and their meaning may not be intuitive to 
comprehend. More studies are needed to correlate the meaning of 
texture parameters and myocardial alterations. 
 
Conclusions 
Advanced MR techniques present a novel quantitative image analysis 
with potential to improve diagnosis and enhance diagnostic 
capabilities compared to conventional qualitative MR imaging. 
The use of CMR image analysis software such as FLORA may give 
an important contribution to the standardization of diagnostic and 
prognostic parameters. The new semiautomated software FLORA 
showed a very high sensitivity in the identification of myocardial 
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LGE. It showed moderate to good agreement with the radiologist in 
the classification of myocardial LGE correctly identifying most of the 
ischemic lesions. FLORA can reduce inter-reader variability in the 
determination of the degree of transmurality of the scar in patients 
with ischemic lesions.  Therefore, FLORA has proven to be an 
applicable tool that improves and facilitates the classification of LGE 
areas allowing their quantification. 
Radiomics with texture analysis could help in the complex CMR 
tissue characterisation discriminating between myocardial diseases 
and improving diagnostic accuracy and confidence. Our study 
showed that some texture features are potentially useful in 
discriminating between myocardial infarction, myocarditis and 
healthy controls. In particular, we found three features after 
dimensional reduction that were significant for both the scanners 
employed. Larger cohort of patients and the use of standardized 
acquisition and reconstruction protocols are further needed to 
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In this section the threshold calculation methods described in the text are 
detailed. 
A histogram, composed of 20 bins, is created from the values of the pixels 
belonging to the myocardium. From this histogram a fit is made with a double 
Gaussian function: 
𝐹 = 𝐴! ∗ 𝑒
! !!!!
!




where 𝐴!, 𝜇! and 𝜎! = 𝑠! 2 are respectively the amplitude, the mean and the 
standard deviation of the first gaussian function and  𝐴!, 𝜇! and 𝜎! = 𝑠! 2 the 
amplitude, the mean and the standard deviation of the second gaussian function. 
The starting parameters of the Matlab fit function are set so that the distribution 
around the maximum of the histogram is fitted with the first gaussian function.  
The Double-gaussian method choose the threshold value (𝑇!) depending on the 
occurrence of the following conditions: 
- if  𝜇! +  𝜎! > 𝜇! and 𝜇! − 𝜎! < 𝜇!, then 𝑇! = 𝜇! +  2𝜎!; 
- if  𝜇! +  2𝜎! < 𝜇! − 𝜎!, then 𝑇! = 𝜇! +  2𝜎!; 
- if  𝜇! +  2𝜎! < 𝜇! − 𝜎! 2 and 𝜇! − 2𝜎! > 𝜇! + 𝜎!, then 𝑇! = 𝜇! −
𝜎! 2 ; 
- if none of the previous conditions are satisfied, 𝑇!  is the minimum 
between 𝜇! +  2𝜎! and 𝜇!. 
The Fixed-shift method threshold (𝑇!) is chosen based on the bin of the 
histogram containing the maximum value (𝐵!"#), according to the following 
conditions: 
- if 𝐵!"# < 15 and 𝜎! is greater than the range of 3 bins, 𝑇! is the value of 
the 5th bin after the 𝐵!"#; 
- if 𝐵!"# < 15 and 𝜎! is lesser than the range of 3 bins, 𝑇! is the value of 
the 4th bin after the 𝐵!"#; 
- if none of the previous conditions are satisfied, 𝑇! is the middle position 
between the 𝐵!"# and the last bin. 
	
